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Overview
This three-part thesis reviews the effectiveness of psychological interventions for
chronic non-cancer pain on healthcare use and sick leave from work, and explores
the process of change in a pain management programme using single case methods.
Part 1 is a meta-analysis of 16 randomised controlled trials of psychological
interventions in a chronic pain population. Small to moderate effect sizes were found
for reduced healthcare use but no significant benefit for sick leave.
Part 2 is a study using single case design methodology to explore trajectories of
change in 8 patients attending a CBT-based chronic pain management programme.
Baseline, intervention and bi-weekly follow-up self-report of catastrophic thinking,
mood, self-efficacy, and goal attainment, and of process variables of working alliance
and adherence, were supplemented by a post treatment change telephone interview
which was qualitatively analysed. Detailed examination of change for each participant
provided rich data: three participants improved significantly over the course of the
programme, three deteriorated, and all improved in at least one goal. Therapeutic
alliance was high and participants rated central elements of the programme,
explanations of their pain, and peer support/group membership as important.
Part 3 is a critical appraisal of the study and the review, contrasting the approaches,
and concluding with a personal reflection on the process.4
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Part 1: Literature Review.
Effectiveness of Psychological Interventions for Chronic Pain on Healthcare
Utilisation and Sick Leave Days. A Meta-Analysis.10
Abstract
Background: Studies have reported that chronic pain tends to be associated with
increased healthcare usage (e.g. doctor or hospital visits, medication) particularly
when it is severe and enduring, or where there are multiple sites of pain and increased
pain related disability. As yet there are no clear evidence for chronic pain and work
absence. Psychological interventions are designed to treat chronic pain and its
sequelae yet there has been no systematic review that has specifically examined its
efficacy for healthcare utilisation (HCU) and sick leave days (SLD) as treatment
outcomes. Aim: To extend a 2012 systematic review of randomised controlled trials
(RCT) to evaluate the effectiveness of psychological therapies for chronic pain in
adults using healthcare utilisation (HCU) and sick leave days (SLD) outcomes.
Method: The 2012 review searches were updated to cover the intervening period. A
systematic search of Cochrane Central Register of Controlled Trials (CENTRAL
2013), MEDLINE, EMBASE and PsycINFO. Sixteen studies met criteria. 12 studies
measured HCU and 9 measured SLD. 13 provided data that were entered into a meta-
analysis. Results: There were small positive effects for psychological interventions
compared to active, treatment as usual (TAU) and waiting list controls in reducing
HCU. The SLD analysis showed no significant effects of psychological interventions,
although there were trends showing reduction overall but not significant. The overall
quality of trials was comparable with the previous review but analysis was restricted
by problems of heterogeneity of reporting metrics, particularly with SLD data.
Conclusions: Since the number of eligible trials was small, it is difficult to draw any
firm conclusions about efficacy. Ideally, a consensus needs to be reached as to which
domains aremeasured and the most appropriate metric to synthesise these outcomes
across trials.11
Introduction
Background
Pain is defined as “an unpleasant sensory and emotional experience
associated with actual or potential tissue damage or described in terms of such
damage” (International Association of the Study of Pain, 1987). Many people have
persistent pain that is not relieved or cured by physical therapy or medicines. Chronic
pain (CP) effects one in five European adults (Breivik, Collett, Ventafridda, Cohen &
Gallacher, 2006) and can have a significant and lasting impact on people's lives,
causing sleeplessness and depression and interfering with normal physical and social
functioning. Ways of coping that are clinically encouraged and adaptive in acute pain
episodes, can become unhelpful and maladaptive in persistent pain (Zarnegar &
Daniel, 2005).
The relationship between thoughts, emotions, biological and behavioural
responses are well documented in the CBT literature (Beck, Rush, Shaw & Emery,
1979, Clark, 1986). Responses to pain are no exception. Unhelpful beliefs and
thoughts, for example, ‘pain means that I am damaging my body’ or ‘moving will
damage my body further and cause pain’, lead to anxiety and fear about movement
and the pain it might cause (Zarnegar & Daniel, 2005). They can therefore become
barriers to revisiting activity, contributing to increased patient disability (Vlaeyen &
Linton, 2000, 2012).
The search for a diagnosis and subsequent pain relief is often unsuccessful.
Patients can spend many years seeking help. They often get stuck in a ‘revolving
door’, seeing a variety of specialists (Clare, Andiappan, MacNeil, Bunton & Jarrett,
2013), which can be damaging both psychologically and physically (Eccleston, 2001).
Unsurprisingly, CP can have a significant impact on patients’ healthcare usage and
healthcare resources in general. Across Europe, Breivik et al. (2006) reported that12
60% of those surveyed with CP had been to see their health care professional
between 2-9 times in the last six months. Yet relatively small numbers have seen a
pain specialist.
CP generates 4.6 million GP appointments per year at a cost of £69 million in
the UK (The Pain Proposal, 2010). Chronic low back pain alone is responsible for
£12.3 billion (22% of total UK healthcare spending) and half a billion pounds is spent
annually by the UK National Health Service on pain medication (Department of Health,
2008). Von Korff, Lin, Fenton & Saunder’s (2007) US based study suggests that
comorbidity of other physical and mental health problems is common in CP and needs
to be factored in when analysing healthcare usage.
Chronic or persistent pain is also a major cause of loss of work days and
underperformance in the workplace (Blyth, March, Brnabic & Cousins, 2004). Twenty
six percent of the 4215 surveyed participants in the pan-European study by Breivik et
al. (2006) had indicated that their pain had impacted on their employment, with an
average of 7.8 days lost to pain-related sick leave in the last six months. UK CP
patients are 7 times more likely to abandon their jobs compared to a healthy
population, while 25% will eventually lose their jobs. CP is also the second most
common reason to claim Incapacity Benefit and a significant economic factor in the
aforementioned 22% UK health care budget spending (DoH, 2008).
In an attempt to understand possible clinical correlates and causation for
increased health care utilisation (HCU) and sick leave days (SLD), a prospective
cohort study of people with chronic lower back pain (Keeley, Creed, Tomenson, Todd,
Borglin & Dickens, 2008) reported that anxiety, depression and fear/avoidance beliefs
relating to work and back pain-related stressors predicted increased healthcare
contacts. In a study of chronic low back pain patients, the authors reported that the
greater the patient’s attention to his or her pain, the greater was perceived pain
intensity and subsequent increased HCU (McCracken, 1997).13
Studies have also reported that chronic pain tends to be associated with
increased use of healthcare, particularly when it is severe and enduring, or where
there are multiple sites and increased pain related disability (Blyth, March, Brnabic &
Cousins, 2004; Von Korff, Wagner & Dworkin, 1991). Other hypothesised
explanations for increased HCU focus on preoccupied attachment style
(Ciechanowski, Sullivan, Jensen, Romano & Summers, 2003) and, in female patients,
on a suggested association in cases where there is a history of sexual abuse
(Finestone, Stenn, Davies, Stalker, Fry & Koumanis, 2000). Studies of SLD data are
less clear. For example, a systematic review by Kuijer, Groothoff, Brouwer, Geertzen
and Dijkstra (2006) suggests that no predetermined set of predictors can be found for
sickness absence in chronic lower back pain, echoing findings from previous studies
(Crook, Milner, Schultz & Stringer, 2002; Elders, van der Beek & Burdorf, 2000;
Truchon & Fillion, 2000; van der Hulst, Vollenbroek-Hutten & Zerman, 2005).
Although there is a body of literature that suggests it may be linked to fear-avoidance
in the work place (Sullivan, Ward, Tripp, French, Adams & Stanish, 2005; Vlaeyen &
Linton, 2012).
Treatments are based on robust psychological principles and practices and
have been in use and in development for about 40 years. Patients are encouraged to
adopt more helpful beliefs and behaviours that lead to less emotional distress and
disability and, to some extent therefore, less dependence on medical services or
withdrawal from everyday activities, including work. Current evidence suggests that
psychological characteristics are more reliable determinants of outcome from CBT
than demographic data, medical diagnosis or physical findings (McCracken & Turk,
2002).
Multidisciplinary Pain Management Programmes (PMPs) are the
recommended treatment of choice for chronic pain (NICE, 2009). They have been
proved to be effective in “reducing negative mood (depression and anxiety), disability,14
catastrophic thinking and, in some cases, pain” (Williams, Eccleston & Morley, 2012.
p2). However, in the current climate, is it enough for a treatment to be solely clinically
effective? For example, PMPs utilise numerous professionals over eight-twelve
weeks and so, as a consequence, could be seen as expensive. But, if they could also
be proved to reduce ineffective healthcare use where patients continue to seek
recourse to healthcare professionals that have no new answers and recommend
treatments that increase the risk of further complications. Therefore reducing HCU
would be good not just for the budget but for the patient’s welfare.
Comprehensive measurement and reporting of psychological outcome data is
already a regular feature of PMP protocols, and so could easily be extended to
behavioural variables such as HCU and SLDs. Clare et al. (2013) used an
appointment system cross referenced for pain visits, to calculate and compare the
costs of secondary healthcare usage one year before and after a PMP. Using an NHS
trust outpatient tariff, they reported a 90.5% saving. Turk (2002) had also made similar
observations in the USA and added that psychological interventions can also reduce
the risk of iatrogenic consequences and adverse events, which can also increase
patient HCU.
The systematic review by Guzmán, Esmail, Karjalainen, Malmivaara, Irvin &
Bombardier (2001) found contradictory evidence of PMP effectiveness on SLDs, with
some studies showing no significant reduction in sick leave whilst others reporting
improvements in work readiness (not the same as SLD as readiness to work may
have little to do with actually getting employment). Whereas the meta-analysis by Flor,
Fydrich & Turk (1992) reported that patients were almost twice as likely to return to
work when treated by a MDT compared with a unimodal intervention or no treatment
controls.
Despite a general acknowledgement of the literature, health care usage and
sick leave days are generally under-reported in studies (Blyth et al., 2004; Van Korff,15
et al., 1991). As a result, little is known about treatment outcome in chronic pain on
healthcare consumption and sick leave. Difficulty in ensuring the reliability of data
might also provide clues as to why it is so under reported. For example, Caudill,
Schnable, Zuttermeister, Benson & Friedman (1991) reported a 36% reduction in
visits to healthcare professionals 12 months after a PMP, but did not differentiate pain
from non-pain visits in their questioning. Cipher, Fernandez and Clifford (2001)
reported fewer visits by chronic pain patients following psychological and medication
treatment, compared with medication only controls, but they questioned the accuracy
of the finding as the data was self-reported and not from medical records.
Whilst collating data for the most recent Cochrane review of the effectiveness
of psychological therapies for the management of chronic pain (Williams et al., 2012),
the authors noted that a small sample of the final studies had measured and reported
healthcare utilisation (HCU) and sick leave days (SLDs) as outcome data. However,
they did not use those outcomes, restricting their meta-analyses to pain, disability,
distress, and catastrophic thinking. Acknowledging the perceived current gap in the
literature, undertaking a systematic review and synthesis of all relevant available data
would seem useful and informative.
Therefore, this study’s objective is to extend the 2012 Cochrane review and
evaluate the effectiveness of psychological therapies for chronic pain in adults,
compared with treatment as usual, waiting list control, or placebo control, to HCU and
SLDs. It will exclude headache which, as reported in the 2012 review, is treated
separately from other chronic pain, aiming to reduce pain intensity, frequency and
duration as much as to help with adaptation. Notably, of the 53 studies included in the
most recent systematic review of headache treatment by psychological methods by
Nestoriuc, Rief & Martin (2008), medication consumption is a common measure of
improvement.16
Aim
To extend the 2012 systematic review by updating the trial set and using
previously unanalysed outcomes of healthcare utilisation (HCU) and sick leave days
(SLD) to evaluate the effectiveness of psychological therapies for chronic pain in
adults, compared with treatment as usual or waiting list controls.
Method
Search Strategy
The 2012 review searches were replicated and extended. RCTs of any
psychological therapy were extracted from the Cochrane Central Register of
Controlled Trials (CENTRAL 2013), MEDLINE, EMBASE and Psychinfo. The
searches focused on the 2 years since the review (January 2011 to October 2013),
using the same search strategy but taking account of changes in search terms or
search processes. Searches of the literature were conducted from the beginning of
the year of the last review to capture any studies that were in the process of being
published or were awaiting classification. An example search strategy is given in
Appendix 1. No language restrictions were applied. Additional studies were identified
using an ancestral approach from the reference lists of retrieved papers.
Inclusion and Exclusion Criteria
In order to ensure accurate replication of trials from the previous review, this
study adopted the same inclusion and exclusion criteria. Studies were included if they:
 were available as a full publication or report of a randomised controlled trial.17
 had a design that placed a psychological treatment1 as an active treatment of
primary interest.
 had a psychological treatment with definable psychotherapeutic content.
 at least one trial arm consisted of a psychological intervention, with at least
one comparator arm of a placebo condition, other active treatment, treatment
as usual or waiting list control.
 were published (or electronically pre-published) in a peer-reviewed science
journal.
 were with participants (aged 18 years or older) reporting chronic pain in any
body site (i.e. at least three months’ duration).
 were not concerned with headache or associated with a malignant life-
threatening disease.
 were with participants meeting criteria for diagnosis of fibromyalgia or chronic
fatigue syndrome.
 had 10 or more participants in each treatment arm at the end of treatment
(returning to previous criteria set out in 2009 Cochrane review criteria to
include previously excluded studies).
 measures healthcare utilisation and/or sick leave days post treatment as a
primary or secondary outcome.
The trials used in the previous systematic review and meta-analysis
(Eccleston, 2009a: Williams et al., 2012) were automatically included if they reported
HCU or SLD data. Previously excluded studies from the 2009 review which met all
inclusion criteria but had N<20 in any arm at the end of treatment were now included
1 A psychological treatment was deemed credible if it was based on an existing psychological
model or framework, and its delivery was by, or was supervised by, a healthcare professional
qualified in psychology18
if they also reported the required data, for maximum inclusiveness. Where there were
either poster abstracts or missing data and contact details were available, authors
were contacted for clarification. Of the 13 authors that were contacted, 1 provided
SLD data (Schmidt, Grossman, Schwarzer, Jena, Naumann & Walach, 2011) and 5
confirmed that they had not measured HCU or SLD outcomes. 7 did not respond to
requests and so this should be considered when assessing the final analysis.
This produced a set of possible titles and abstracts. From these, one rater
(AP) selected for examination all full papers that appeared to meet inclusion criteria.
Both authors read the papers independently and agreed on which trials were eligible.
The final set of papers (including those now eligible from the previous systematic
review) were rated independently for risk of bias and quality. Consensus was
established between raters where there were disagreements in rating scores.
Results of the Search
This review identified 25 randomised controlled trials that reported HCU or
SLD data. Ten trials were from the 2012 Cochrane review (Alaranta, Rytokoski,
Rissanen, Talo, Ronnemaa, Puukka et al., 1994; Geraets, Goossens, de Bruijn, Koke,
de Bie, Pelt et al., 2006; Jensen, Dahlquist, Nygren, Royen & Stenberg, 1997 and
Jensen, Bergstroem, Ljungquist, Bodin & Nygren, 2001; Kaapa, Frantsi, Sarna &
Malmivaara, 2006; Lindell, Johansson & Strender, 2008; Schmidt et al., 2011;
Thieme, Gromnica-Ihle & Flor, 2003; Turner, Mancl & Aaron, 2006; Williams,
Richardson, Nicholas, Pither, Harding, Ridout et al., 1996) and 5 excluded trials with
N < 20, from the previous 2009 review (Ersek, Turner, McCurry, Gibbons, Miller &
Kraybill, 2003; Flor & Birbaumer, 1993; Johansson, Dahl, Jannert, Lennart &
Andersson, 1998; Marhold, Linton & Lennart, 2001; Moore & Chaney, 1985). Two
were identified from reference lists of other studies (Turk, Rudy, Kubinski, Jazaki &19
Greco, 1996; Busch, Bodin, Bergstrom & Jensen, 2011) and eight trials from the new
search (Bendix, Bendix & Ostenfeld, 1995 & Bendix, Bendix, Vaegter, Lund, Frølund
& Holm, 1996; Gustavsson, Denison & Koch, 2011; Huibers, Beurskens, Van
Schayckk, Bazelmans, Metsemakers, Knottnerus et al., 2004; Overmeer, Boersma,
Denison & Linton, 2011; Sattel, Lahmann, Gundel, Guthrie, Kruse, & Noll-Hussong et
al., 2012; Van Eijk-Hustings, Kroese, Tan, Boonen, Bessems-Beks & Landewe,
2013).
Excluded studies. Nine of the 25 studies were excluded on closer
examination. Bendix et al. (1995 & 1996) and Vibe-Fersum et al. (2012) due to
insufficient psychological content; Huibers et al. (2004) and Sattell et al. (2012) did
not sample chronic pain patients and Gustavsson et al. (2011) used physiotherapists
to provide psychological treatment; details suggested low quality of therapy. Three
studies provided HCU and SLD data not as outcomes but as a baseline measures
only (Ersek et al., 2003; Overmeer et al., 2011; Turner et al., 2006).
Data extraction and management
Descriptive characteristics of participants and treatments including setting,
mode of delivery, and treatment data were collected. However, the primary area of
interest for this review was outcomes in the domains of post-treatment HCU and
SLDs. HCU eligible data was defined as any mainstream health service resources
which were freely available (or referred to if under an insurance-based healthcare
system) to patients and measured post treatment. Generally recorded as numbers of
visits by patients to general practitioners/doctors/physicians, physiotherapists,
osteopaths, specialists, chiropractor, nurse or other healthcare professionals.
Also acceptable were more generic terms such as doctor visits, outpatient
medical resources, medical visits and hospital days or healthcare visits. Not all were20
corroborated as pain-related due to the method of data collection i.e. self-report or
general medical records. Some were non-specific as to the nature of the visit or a yes
or no answer to the specific question about healthcare usage. However, for the
purposes of this study they were considered eligible. Less traditional alternative
therapies or complementary medicines were not included in the data as they were
considered non-mainstream healthcare resources. Medication prescription and usage
was also included as HCU data.
Eligible SLD data was any post treatment measurement of sick leave or
absence from work and were typically recorded as days or numbers of episodes from
either self-report, insurance-based or work-based records. Identifiable terms such as
sick leave days, sick days, work absence, sick leave greater than 14 days, or sick
listed days were eligible. There was significant variation in the methods of reporting
or analysis, varying from yes or no answers to a specific question about SLD to
categorising patients by their number of sick leave days or reporting group
percentages. There was also variation in the time point of measurement. This was
further considered at the analysis phase of this study.
Data Analysis
Due to the variation in methods of data collection and reporting of healthcare
utilisation and sick leave days in the studies, this review included both continuous and
dichotomous scales. Where continuous data were reported, treatment effects were
estimated using standardised mean differences by extracting means, standard
deviations and sample size at follow-up, and random rather than fixed effects given
the likely heterogeneity (Higgins & Green, 2011). Where data were dichotomous,
treatment effects were estimated using odds ratios by extracting and calculating
number of events data and sample sizes at follow-up. When data were not available
from published studies or from authors, no parameters were inferred. All meta-21
analyses were conducted using Review Manager (RevMan) [Computer program] (The
Cochrane Collaboration, 2012).
Figure 1: PRISMA (2009) Study flow diagram22
Quality of Studies
Risk of bias was assessed using the recommended Cochrane guidance
(Higgins & Green, 2011). Of the five suggested ’Risk of bias’ categories, random
sequence generation (selection bias), allocation concealment (selection bias),
blinding of outcome assessment (detection bias), incomplete outcome data (attrition
bias) and selective reporting (reporting bias) were included. The option of ’blinding
participants and personnel’ was excluded because neither therapists nor patients can
be blinded to whether they deliver or receive treatment. As in the previous reviews
(Eccleston et al., 2009a, Williams et al., 2012), a quality rating scale specifically
designed for psychological interventions in pain was applied (Yates, Morley,
Eccleston & Williams, 2005). Two authors (AP, AW) scored all studies and they
reached a consensus after initial comparison or ratings.
The scale (see Appendix 2) provides an overall total score (0 to 35) consisting
of two subscales: a treatment quality scale (0 to 9) covering stated rationale for
treatment, manualisation, therapist training and patient engagement; and a design
and methods scale (0 to 26) covering inclusion/exclusion criteria, attrition, sample
description, minimisation of bias (randomisation method, allocation bias, blinding of
assessment, equality of treatment expectations), selection of outcomes, length of
follow-up, analyses and choice of control. The first four ’Risk of bias’ items from the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins, 2011) are
represented in the design section of the Yates et al. (2005) scale, accounting for up
to five of the nine points available.
Measures of Treatment Effect
Studies where psychological treatment was as an active treatment of primary
interest were investigated. Most studies used cognitive behavioural therapy or
behavioural therapy as an arm of treatment or as part of a multi-disciplinary approach23
to treatment. Three classes of comparator treatments are investigated and labelled
active control, treatment as usual and wait list. The active comparator involves a
treatment designed to manage pain such as physical therapy, education or medical
regime.
Patients randomised to the active control within each trial all receive the same
treatment. For patients assigned to waiting list, trials vary in whether they provide
further care and patients vary in whether they seek further care. For patients assigned
to treatment as usual, this treatment can consist of anything from regular consultations
or care to nothing; waiting list patients may also receive some or no treatment. Thus,
patients in these conditions receive variable and usually unrecorded treatment.
Where a trial had more than two arms, treatments that were either more
robust, which best matched description of a psychological intervention and, where
there was a choice, the more intensive version, were selected: for example, if a trial
had an enriched CBT (that is, CBT with additional non-core components such as
biofeedback), a minimum CBT and a waiting list condition, we compared the enriched
CBT with the waiting list.
This review endeavoured to align assessment time points at follow-up. Follow-
up is the assessment point at least three months after the end of treatment, but not
more than 24 months, and the longer of the two if there were two follow-up
assessments within this timeframe. Therefore, 2 comparisons were designed
comprising the class of psychological treatment under investigation, one of the three
forms of comparator (active control, treatment as usual, waiting list), and one best
aligned assessment time point (follow-up). They are labelled: Psychological
Intervention versus treatment control - HCU and Psychological Intervention versus
treatment control - SLD.
For each comparison we identified two outcomes of interest i.e. healthcare
utilisation and sick leave days. Although standard trial reporting guidance promotes24
the definition of primary outcomes (Boutron, Moher, Altman, Schulz & Ravaud, 2008),
most of the included trials reported HCUs or SLDs as secondary outcomes.
Risk of Bias in Included Studies
This study adopted five ’Risk of bias’ categories: random sequence generation
(selection bias), allocation concealment (selection bias), blinding of outcome
assessment (detection bias), incomplete outcome data (attrition bias) and selective
reporting (reporting bias). Four of the final 14 studies had not been rated previously
by the 2009 and 2012 reviews (Busch et al., 2011; Flor et al., 1993; Turk et al., 1996;
Van Ejik-Hustings et al., 2013) and so it seemed sensible to follow the same risk of
bias procedures.
Assessment of Heterogeneity
Between-trial heterogeneity is automatically calculated in RevMan and
expressed using the I² statistic. I² values above 50% indicate high heterogeneity,
between 25% and 50% medium heterogeneity, and below 25% low heterogeneity.
Results
Included Studies
The full characteristics of all included studies are detailed in tables in appendix
3. There were only two eligible new studies since the previous Cochrane review that
report HCU or SLD data. All included trials represented a total number of participants
of 1873 at the end of treatment (mean per study 117, SD 72) out of the 2084 that
started treatment. This equated to a mean study completion rate from point of entry
to completion of 88.5% (SD 7.5%) and ranged from 73.5% - 100% using data from all
16 studies. 1441 women (mean 91 SD 55 range 1-195) and 623 men (mean 39, SD25
42, range 0-133). Women usually outnumbered men (mean 69 %; SD 26%; range 2%
- 100%). The mean age was 45 (range 33 - 53) and mean duration of pain symptoms
from those that provided data (12 of the 16 studies) was 3.9 years (range 1.3 - 16.3).
Participants were recruited from numerous sources. Seven studies used
patients from pain/rehabilitation clinics (including one veterans’ hospital; three treated
patients from outpatient clinics); 2 used primary care referrals. Not all studies sampled
solely patients. One study advertised for volunteers in a newspaper to supplement
referrals from GPs, specialists, and a patient self-help group; 2 studies sampled
community volunteers; 1 study recruited current employees from a national insurance
authority register in Sweden. Half of the 16 studies were from Scandinavian countries
with 6 trials from Sweden, and 2 from Finland. Three were from Germany, 2 from the
Netherlands, 2 from the USA and 1 from the UK.
Three studies were solely for patients with fibromyalgia; two studies were
solely for low back pain; 3 treated mixed back or neck pain; one study focused solely
on shoulder pain; another recruited chronic back pain or temporomandibular joint pain
patients; 3 were mixed pain sites as long as it was of greater than three months
duration; one study was solely temporomandibular joint pain and 2 studies recruited
chronic musculoskeletal pain patients.
Nine studies had 2 arms, 4 studies had 3 arms and 2 studies had 4 arms.
There was a significant diversity in types and modalities of psychological intervention
such as intensive physiotherapy and psychosocial therapy, graded exercise therapy,
group rehabilitation, CBT, operant pain therapy, biofeedback, behavioural
management, behavioural therapy, couple therapy, multi-disciplinary therapy and
mindfulness based stress reduction. Control or comparator arms, if not treatment as
usual or a wait list control, were medical intervention or individual physiotherapy. Each
study was scored for quality of treatment, which produced a mean 5 (SD 1.96 range26
= 2-8) and study and design quality, which produced a mean 16.43 (SD 3.80 range =
11-23).
Of the sixteen remaining studies 13 provided analysable data (Alaranta et al.,
1994; Flor et al., 1993; Geraets et al., 2006; Jensen et al., 2001; Kaapa et al., 2006;
Lindell et al., 2008; Marhold et al., 2001; Moore et al., 1985; Schmidt et al., 2011;
Thieme et al., 2003; Turk et al., 1996; Van Ejik-Hustings et al., 2013; Williams et al.,
1996). The results of the remaining trials are summarised in the results.
Unit of Analysis Issues
There was significant disparity in how HCUs and SLDs were measured in each
of the final studies which made data synthesis and analysis more difficult. Twelve
studies measured HCU – Alaranta et al. (1994); Flor et al. (1993); Geraets et al.
(2006); Jensen et al. (2001); Kaapa et al. (2006); Lindell et al. (2008); Moore et al.
(1985); Schmidt et al. (2011); Turk et al. (1996); Thieme et al. (2003); Van Ejik
Hustings et al. (2013); Williams et al. (1996). Table 1 describes the HCU metric
extracted from each trial and calculated summary statistic for comparison.
Nine studies measured SLDs Alaranta et al. (1994); Geraets et al. (2006);
Kaapa et al. (2006); Jensen et al. (1997) and (2001); Johansson et al. (1998); Lindell
et al. (2008); Marhold et al. (2001). Table 2 describes the SLD metric extracted from
each trial and calculated metric applied for comparison.27
Table 1.
Derived metrics from HCU trials and calculated summary statistics
Study Metric Summary Statistic
Used
Analysed
Alaranta 1994 Doctor and O/P
visits
Percentage
Difference
Not analysed
Flor 1993 Pain related
healthcare visits
Mean & Sd Analysis 1.1
Geraets 2005 Mean utilisation of
various HCPs
Pooled means and
Sd
Analysis 1.1
Kaapa 2006 Mean no of
healthcare visits to
various
Mean and Sd Analysis 1.1
Lindell 2008 Mean group visits
to HCP acute and
sub-acute
Mean only no Sd Not analysed
Moore 1985 Mean outpatient
visits (pain & non-
pain) from med
records
Mean and Sd Analysis 1.1
Thieme 2003 No. of doctors
visits.
Mean and Sd Analysis 1.1
Van Eijk-Hustings
2013
Mean no of
contacts with
various HCPs
Pooled mean and
Sd of all
categories of visits
Analysis 1.1
Schmidt 2011 Count of yes/no
answers to any
pain related
medical visits
Count of visits Analysis 1.2
Turk 1996 Self-reported use
of prescribed and
over the counter
analgesic
medication
Counts of self-
reported meds
Analysis 1.3
Williams 1996 Number of
patients surgery,
pain relieving tx &
manipulative tx
Counts of self-
reported meds
Analysis 1.2 & 1.328
Table 2
Derived metrics from SLD trials and calculated summary statistics
Quality of Studies
A full summary of risk of bias assessment are detailed below in figures 2 and 3.
Allocation (selection bias). Five studies described a convincing method of
randomisation and were judged to have a low risk of bias, and a further 8 provided an
inadequate description so were judged to be unclear. Three had a high risk of bias,
mainly because the method of randomisation was not described; two of these studies
were almost 20 years old.
Study Metric Summary Statistic Analysed
Alaranta 1994 group percentage
grouped into
numerical bands
No of events > 30
days
Analysis 2.3
Geraets 2005 Mean days Mean and Sd Analysis 2.1
Kaapa 2006 group percentage
grouped into
numerical bands
No of events > 30
days
Analysis 2.3
Jensen, 1997/2001 Mean working days
lost per year
Calc net days –
possible days
Analysis 2.2
Johansson. 1998 Mean percentage
after 1 month
No summary Not analysable
Lindell, 2008 Net sick days in 6
month periods
Calc net days –
possible days
Analysis 2.2
Marhold, 2001 Mean sick leave
days
Mean and Sd Analysis 2.129
Seven studies were judged to have adequate allocation concealment, five
uncertain and four high risk, again mainly because there was no description of
designated procedures.
Blinding (performance bias and detection bias). Four studies were judged
at low risk of bias for outcome assessment since they used blinded assessors; eight
were unclear; and four at high risk of bias since they gave no details of outcome
assessment procedures. It should be borne in mind, however, that almost all
outcomes were assessed by self-report so that there were restricted opportunities for
influencing patients’ scores. Thus most judgements of high risk of bias were because
of inadequate reporting. This study recognises this is that some studies may have
exercised proper precautions in some or all of these areas.
Incomplete outcome data (attrition bias). Four studies reported attrition
fully, including finding no difference between dropouts and completers, and were
judged to have low risk of bias; six were unclear risk, mainly because of lack of testing
for differences between dropouts and completers; six were judged to have high risk
of bias, predominantly because they provided no or implied details of attrition or were
only partially reported.
Selective reporting (reporting bias). Thirteen studies were at low risk of bias
for selective reporting of outcome since they reported all outcomes; three studies did
not report all outcomes which they described in assessment sections of their Methods,
and so were judged them at high risk of bias.30
Figure 2: Risk of bias graph: review authors' judgements about each risk of bias item
presented as percentages across all included studies.
Figure 3: Risk of bias summary: review authors' judgements about each risk of bias
item for each included study.
Other potential sources of bias. The comprehensive quality assessment scale
(Yates, 2005) is reported in the characteristics of included studies. For the 16 studies
which met the inclusion criteria, the mean overall quality of the studies was 21.0 (SD
4.8, range 15 to 31). The mean treatment quality score was 5.1 of a possible 9 (SD
1.8, range 2 to 8) and the mean design quality score was 16.0 of a possible 26 (SD
3.8, range 11 to 23).31
Of the 5 analyses reported (intervention versus treatment control for HCU mean
difference, HCU Events, Sick Days, Net Group Sick Days, Sick Days > 30), 4 showed
low heterogeneity of less than 25%, none showed moderate heterogeneity of greater
than 25% and less than 50%, and one showed high heterogeneity greater than 50%.
Effects of Interventions
Intervention versus treatment control - healthcare utilisation. Six trials reported
mean and SD for HCU as visits, contacts or use of GPs, physicians, physiotherapists,
outpatient medical resources, nurses, medical specialists and paramedical specialists
and other healthcare professionals over 6-12 month follow-up periods involving 563
participants. They were analysed for the effect of psychological intervention on
healthcare utilisation using standard mean difference.
Table 3.
Analysis 1.1
The initial overall effect was non-significant (Z=1.23, P>0.05). However, the
heterogeneity was 89%. The previous review (Williams et al., 2012) had noted the
significant contribution to heterogeneity of the Thieme et al. (2003) study and so it
was deemed prudent to experiment with, first, the removal of studies until
heterogeneity was acceptable. Removal of the Thieme et al. (2003) study and the Van32
Eijk Hustings et al. (2013) study reduced I² value to 0% and gave a significant benefit
(Z=2.57, P<0.05) with small effect size of -0.28 (CI 95% -0.49, -0.07) in favour of
reduced visits in the treatment (labelled experimental) condition. Exploring the
reasons for the high heterogeneity of these two trials was not in this study’s remit.
Specifically, the four trials included in the final analysis measured pain related
healthcare visits at 6 month follow-up (Flor et al., 1993); patient utilisation of GP,
physician, physiotherapist and manual therapists at 12 months (Geraets et al., 2006);
mean number of visits to physician, physiotherapist and other health care
professionals at 12 months (Kaapa et al., 2006); and use of outpatient medical
resources at 8 months (Moore et al., 1985).
Table 4.
Analysis 1.2
Two trials of 197 participants during a 2 -12 month follow-up period were
analysed using a risk ratio. Data indicated a positive response to the experimental
condition. The test for overall effect was very significant (Z = 2.82; P = 0.005) in favour
of the treatment (experimental) condition with a risk ratio of 0.72 [95% CI 0.58, - 0.91]
but there was high heterogeneity (I² = 63%).33
Table 5.
Analysis 1.3
Two trials of 102 participants were analysed for effects on pain medication
use. Turk et al. (1996) reported the percentage of self-reporting participants using
over the counter analgesic medication at 6 monthfollow-up. A risk ratio was calculated
using N values from Williams et al. (1996) of self-reporting participants using “no
drugs” subtracted from the group N value to calculate those that were using pain
medication. The percentages in the Turk et al. (1996) study were then converted to
actual participants to provide a number of events metric for analysis (specific pain
medications were also reported in Williams et al. (1996) but did not include analgesics
and so this was deemed as the closest metric for analysis). The test for overall effect
was positive (Z = 4.18, P = 0.0001) with a risk ratio of 0.33 [95%, 0.19, -0.55] in favour
of the intervention and low heterogeneity at (I² = 4%).
The excluded studies which increased heterogeneity showed significant
results when comparing treatment arms. Thieme et al. (2003) reported a significant
interaction of group and time for female fibromyalgia patients and only the
psychological intervention group reduced doctor visits (53.5%) and hospital days
(80.3%). There was a significant reduction in use of anti-depressant medication, non-
steroidal anti-inflammatory drugs and opioid medication. However, they used mean
and SD metrics which could not be added to the medication analysis. Van Eijk-
Hustings et al. (2013) reported within a multi-disciplinary therapy (MDT) significant
reduction in GP visits compared toTAU controls. Within boththe MDT andTAU group,34
a significant reduction was observed in specialist visits during the study. A small non-
significant reduction in medical visits between MDT & TAU in favour of TAU was
reported at the end of the intervention.
There were small to moderate significant effect sizes for psychological
interventions on HCU. The remaining trials with HCU outcomes that did not provide
analysable data reported mixed findings. Alaranta et al. (1994) reported that visits to
doctors at 12 months follow-up compared to the 12 months pre-treatment diminished
by 74% in the treatment group compared to 67% in the control group and that
outpatient physiotherapy visits reduced by 66% in the treatment group and 77% in
controls. Lindell et al. (2008) was less convinced of treatment effects between CBT
and primary care, acute and chronic pain patients but did acknowledge a trend in
reduction of HCU that was sustained up to 18 months follow-up .
Intervention versus treatment control - sick leave days.
Table 6
Analysis 2.1
Two trials totalling 248 participants were analysed for the effect of
psychological intervention on mean sick leave days for paid and unpaid work (Geraets
et al., 2005) and those on long term sick leave (Marhold et al., 2001). The overall
effect was non-significant (Z=0.53, P>0.05).35
Table 7.
Analysis 2.2
Two studies with 220 participants provided total sick days converted to events
as the metric for analysis. It was calculated over a 26 week period, which assuming a
five day working week would equal 130 days. Therefore the total number of sick days
for the sample is 130*N and the calculated non-sick days (130*N)-net sick days
reported in both studies and divided by 1000 (so that events were not bigger than the
number of participants). Based on these calculations for each study, effect sizes were
non-significant with a risk ratio of 0.99 [CI 95% 0.84, 1.15].
Table 8.
Analysis 2.3
Two studies with 388 participants were selected for risk ratio analysis. The two
studies grouped percentages of participants by the number of sick days reported over
12 months. Percentages were converted to actual participants and combined with the
subgroup ‘participants with greater than thirty days sick leave days’ which both studies
reported post treatment. The overall effect was non-significant (Z=0.25, P = 0.80) with
a risk ratio of 1.05 demonstrating no difference between intervention or control.36
There were no significant effects of psychological interventions and control
groups on sick leave days. Of the studies that could not be analysed, Johansson
(1998) reported no effect of inpatient CBT on sick leave compared with wait list
controls. The authors suggest this may be explained by follow-up being too short (1
month) considering improvement patients had shown in other areas of disability. A
replication of the same study with follow-up at 1 year reported a decrease in average
level of sick leave from 70% pre-treatment to 29.4%. The 10 year follow-up by Busch
et al. (2011) of Jensen et al. (2001), whilst not included in any of the analyses, also
reported no significant between-groups results but, observed that MDT interventions
reduced sickness absence by 42.98 days/year compared to TAU.
Discussion
A systematic review and meta-analysis of the effectiveness of psychological
interventions in reducing healthcare use and sick leave days in chronic pain patients
included sixteen studies that compared psychological interventions with treatment as
usual, waiting list or active controls.
Summary of Main Results
The primary objective of this review was to evaluate the effectiveness of
psychological therapies for chronic pain in adults using previously unanalysed
outcomes of healthcare utilisation (HCU) and sick leave days (SLD). This review
found 25 trials of which 16 were eligible and provided data representing 1873
participants from 6 different countries with a mean age of 45 and mean pain duration
of 3.9 years. Twelve measured healthcare utilisation and nine used sick leave days
as outcomes, with fifteen trials providing data suitable for analysis; 9 for HCU and 6
for SLD. Psychological interventions were predominantly based on CBT principles, or37
adaptations of CBT, as part of combined exercise, medication or stress reduction
interventions.
Meta-analysis demonstrated small but positive effects for psychological
interventions compared to active, treatment as usual (TAU) and waiting list controls
in reducing HCU. The SLD analysis showed no significant effects of psychological
interventions, although there were trends showing reduction overall but not significant
when compared with active and TAU controls. The overall quality of trials was
comparable with the previous review but analysis was restricted by problems of
heterogeneity of reporting metrics, particularly with SLD data.
Inpatient PMP performed more favourably than an outpatient PMP across
healthcare usage including self-reported medical appointments and self-reported
medication use (Williams et al., 1996). Similar results were found in a mindfulness
based stress reduction intervention and active relaxation controls (Schmidt et al.,
2001).
All psychological (e.g. CBT, couple CBT and MDT rehabilitation) and control (e.g.
medication, individual CBT and individual physiotherapy) interventions reduced HCU,
and there was no difference between the magnitude of these benefits between
psychological and control conditions, with the exception of one trial. In Flor et al.
(1993), the biofeedback control condition had greater long-term improvements for
HCU than the psychological intervention. The authors suggest that patients with few
physical disabilities in a musculoskeletal pain population may benefit more from short
term biofeedback treatment.
There were also reported significant reductions in medication usage but not
all studies were able to be analysed together due to the difference in measurement.
The two studies compared by risk ratio elicited a small effect in favour of psychological
intervention. They both reported significant results between intervention and controls38
and were both forms of pain management programs that generally perform well in
reducing medication.
Closer examination of the individual studies suggests that whilst there was a
general towards reduction in SLD post intervention, there were no noticeable effects
between psychological interventions and control groups. Most trials reported a
general reduction in SLD in both intervention and active control arms but it was not
significant between intervention and control groups. The earlier review of the literature
would concur with these findings with SLD studies reporting conflicting findings
although the difficulties in calculating summary statistics with the SLD data was
problematic and so further investigation is needed.
Quality of the Evidence
Using the Yates et al. (2005) quality rating nomenclature, the mean score of
the sixteen studies was 21/35, with a range between 15 and 31. It is difficult to
ascertain what effect this has on the final analysis but should be considered when
measuring the final results. The overall quality of trials was comparable with the
previous review (Williams et al., 2012) but analysis was restricted by problems of
heterogeneity of reporting metrics, particularly with SLD data. Therefore it is difficult
to report these effects as conclusive.
Agreements and Disagreements with Other Studies or Reviews
This review’s findings tend to agree with previous studies of HCU data. For
example, a study compared cost-effectiveness of three treatment groups by
examining treatment outcome, post treatment health care costs, and post-treatment
health care visits (Cipher et al., 2001). Results revealed that patients receiving both
medical and psychological treatment (multidisciplinary pain management) exhibited
the largest improvements in functional capacity, whilst being the least costly after their39
treatment program had ended. In contrast, patients who received only medical
treatment exhibited significant deterioration in outcome after their treatment ended,
and used three or more times post treatment health care in dollars.
Trials indicate multidisciplinary pain management programmes reduced HCU
and SLDs. Flor et al. (1992) cited both HCU and SLD reductions in their meta-analysis
of pain treatment centre efficacy. They reported a 50% return to work after PMP and
that 25% of disability claims are closed with a one third reduction in the number of
surgeries and hospitalisations. Hoffman, Papas, Chatkoff & Kerns (2007) meta-
analysis of psychological effects for chronic lower back pain reported the opposite of
this reviews findings. They report no effect of psychological interventions on HCU and
HC visits (where 36% of 22 studies had reported HCU data). However, there was a
moderate effect size of MDT for long-term return to work outcomes.
This study recognises the lack of trials that measure both HCU and SLD
outcome data. Of the 71 screened trials only16 used HCU or SLD outcomes. When
one considers that most pain management interventions explicitly aim to reduce
healthcare use/costs and have been proven to reduce disability that can hinder return
to and maintenance of employment (Flor et al., 1992; Hoffman et al., 2007) the small
number of trials is surprising. Over 50% of data from included studies were from
Scandinavia, particularly for SLD data that can be accessed through a national
registry. Importantly, it remains unclear how generalizable these findings are to other
Western countries, including the UK.
Implications for Practice
A recent report commissioned to assess the current impact of chronic pain in
Europe, highlight current management failings and share good practice, outlines
some of the current systemic measurement issues affecting progress:40
“A significant barrier in initiating change at a political level, is the lack of clinical
and economic measurement for chronic pain. … there is no evidence to show
that effective management of chronic pain can result in a decrease in hospital
admissions although common sense tells us that there is likely to be a
relationship between the two. Chronic pain is essentially ‘invisible’ within the
NHS, and so the evidence to support calls for improved diagnosis,
management and interventions from a political level is lacking. This problem
is compounded by the lack of outcome data from ‘effective’ services and lack
of data on the economic impact of chronic pain.
(The Pain Proposal, 2010; p11)”
Knowing which subgroups of chronic pain respondents use the most services
and what types of services or are the most vulnerable to employment issues such as
sick leave, provides some of the information needed for good health services policy
and planning (Blyth et al., 2005). This review highlights how little is currently known
or reported in these areas of pain research and yet the indicators are that it is
something that health providers are requesting. Most services are funded according
to the number of patients seen, rather than the complex services they provide. Where
new and innovative ways of working reduce the number of patients who need to be
seen in specialist clinics, this can result in a significant loss of funding for the service,
further discouraging innovation and threatening the viability of local services.
Pain management claims to enable self-management and reduce recourse to
healthcare use. Despite some good supporting evidence reviewed in this study, this
needs to be demonstrated. A number of reports cite the significant cost of pain to the
health budget, therefore there is a need to show cost effectiveness, however
beneficial treatment is to the patient in other ways. It is true that perhaps there are
issues around obtaining reliable accurate data e.g. the accuracy of self-report data.41
They can pose threats to validity when incorporating them into RCT yet it has been
achieved successfully by a number of studies, as we have seen in this review.
HCU and SLD factors are common complaints from patients when entering
treatment and are actively discussed, yet it appears not to be regularly monitored or
reported. Fear and anxiety, high levels of pain and high levels of disability or the need
for certification for welfare or sick pay can be important reasons for patients to seek
help. The time and money spent getting to appointments or the results of
treatments/consultations can also cause unwanted psychological effects for patients.
Therefore collection and analysis of HCU and SLD data already fits with the existing
self-help ethos of pain management intervention.
Willingness and understanding of employers is also a factor in addressing
SLDs. Return to, or remaining in, employment needs more than just psychological
rehabilitation. For example, a prospective cohort study surveying CLBP patients in an
orthopaedic outpatient setting for predictors of HCU reported work-related fear
avoidance as a significant factor (Keeley et al., 2008). If the causation of increased
HCU is assessed to be employment related, there is an opportunity for health care
professionals to intervene effectively at both a work, and a health care level.
Practical support at the employer level is required. Helping employers to
become ready to accept those that have been put off employment for so long as well
as meeting the risk and expense of workplace adaptations must be part of the
solution. There is comprehensive NICE guidance on how to approach the treatment
of people with long term sickness absence and they recommend joint working
between health care professionals and employers during treatment (NICE, 2009).
Implications for Research
The findings of this research were consistent with prior research on the
variation of reported metrics, particularly for the SLD data. The meta-analysis by Flor42
et al. (1992) of psychological interventions for pain, reports their study was also
‘hampered’ by failures to report extractable data. In some circumstances they had to
rely on graphical display to determine the required outcome data. This review
highlights a need for development of common measures of HCU and, in particular,
sick leave data. Future research could focus on establishing a consensus amongst
providers and professionals alike in order to facilitate valid and reliable comparisons
in meta-analyses. The current high levels of heterogeneity across metrics make it
difficult to synthesise the outcomes across trials and, therefore, inform decision-
making.
The use of national registry of sick leave data, as demonstrated by the
Scandinavian based studies, would appear to be the solution to the reliability issues
but has some limitations. For example, it usually relies on the absentee reporting the
reason for the leave and sometimes records episodes of leave and so 3 days may be
calculated as one week (Ostelo & de Vet, 2005). There is evidence against the
convergent validity of registry and self-report data (Burdorf, Post & Bruggeling, 1996;
van Poppel, de Vet, Koes, Smid, & Bouter, 2002). Both studies measured sensitivity
(the percentage of people with back pain who report sick leave in the registry) and
specificity (the percentage where the patient had reported no incidents of sick leave
where there had been none). Specificity was high meaning that generally tallied with
the registry. Sensitivity varied from 88% (Burdorf et al., 1996) to 55% (van Poppel et
al., 2002). Both found sensitivity was dependant on the period of recall, the level of
education of the reportee and the duration of the period of the sick leave.
Patient medication diaries or self-reported medication usage can offer richer
data of actual consumption rather than a record of prescription alone. It can elicit
patterns of consumption, adherence and supplementary medications that solely
interrogating prescription records perhaps cannot. For example, self-reporting could
also encompass over-the-counter medication such as non-steroid anti-inflammatory43
drugs that may not be recorded as they are not generally prescribed medications.
This approachto HCU and SLD outcomes has been observed successfully inWilliams
et al.’s (1996) RCT where patients successfully completed healthcare and medication
usage.
A recent study on patient-defined measures of clinical outcomes following a
focus group, were rated by people with chronic pain. Employment was rated as an
important measure by almost 70% of respondents (Beale, Cella & Williams, 2011).
When one considers the social, physical and financial costs of excessive sick leave,
this is perhaps no surprise (Vingård, Alexanderson & Norlund, 2004). It is unclear
from the study by Beale et al. (2011) whether the same study population would rate
HCU as highly as employment or if they would consider it worthy of measurement.
Medication understanding and usage is usually high on a patient’s list of concerns
coming into treatment. HCU outcomes could also be linked to quality or enjoyment of
life which was also rated highly as a desired measure. HCU perhaps has some
influence here in terms of unwanted side effects or unnecessary visits to doctors or
hospitals.
Conclusion
This review demonstrated small positive effectsfor psychological interventions
compared to active, treatment as usual (TAU) and waiting list controls in reducing
HCU. The SLD analysis showed no significant effects of psychological interventions,
although there were trends showing reduction overall but not significant when
compared with active and TAU controls. The overall quality of trials was comparable
with the previous review but analysis was restricted by problems of heterogeneity of
reporting metrics, particularly with SLD data. Only 25 trials from a possible 71 reported
HCU and SLD data with 16 providing suitable data for this review. When one
considers the health care provider’s focus on economic as well as clinical44
performance, the small number of studies is surprising. There are undoubtedly some
benefits here for pain management programmes when one compares the general
trends in efficacy shown in these outcomes particularly for HCU with the ease of
implementing the data collection. Routine measurement of HCU and SLD outcomes
could become part of assessment and treatment protocols and could not only justify,
but increase funding for what is generally considered as an expensive intervention.
This review, therefore, makes the following recommendations:
1. A commitment to measurement to be included in all future pain trials of HCU
and SLD data e.g. number of visits, days, periods of absence.
2. An agreed metric for reporting HCU and particularly SLD data to improve ease
of analysis and comparison e.g. individual or group means and SDs.
3. Identification at assessment of patients with significant HCU or employment
difficulties assessed to be interfering with quality of life. For example,
employment issues are measured on the Sickness Impact Profile and so could
be explored further.
4. Regular reporting of pre, post and follow-up HCU and SLD outcome data from
healthcare teams to commissioners, managers and a national database.45
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Part 2: Empirical Paper
“The parts are greater than the sum of the whole”
Exploring the Process of Change in a Pain Management Programme using
Single Case Study Design55
Abstract
Aims: Cognitive Behavioural Therapy (CBT) has been proven as an effective
treatment in the management of chronic pain although it is not yet understood what
components of treatment are most influential for beneficial outcomes. Building on
previous findings of multicomponent multi-outcome Randomised Controlled Trials
(RCT), this study uses an idiographic approach to identify relationships or trajectories,
which might lead to hypotheses about participant change in a CBT pain management
programme.
Method: Eight participants were recruited from a London based pain management
programme using twice weekly measures selected for previous evidence of
efficacious change from pain management interventions i.e. mood, self-efficacy,
catastrophic thought, goal attainment, adherence and working alliance. Participants
completed measures at a baseline, intervention and follow-up period. A telephone
interview was also carried out.
Results: One participant made significant improvement across all measures and 3 in
self-efficacy and mood. 3 participants showed significant deterioration in self-efficacy.
All participants made progress on agreed goals and some potential associations were
found with adherence. There was a high and consistent consensus in working alliance
and participants agreed that CBT, pacing, explanation and biology of pain, therapeutic
alliance, and peer support were contributing factors in their change. Graphical
representation of scale scores indicates the fluctuation in scores across the three
phases.
Conclusion: Single case methods provide further insight as to the trajectory of
change for individual participants before, during, and after a pain management
programme. They also offer some insight into possible components of change and
the fluctuation of scores that are sometimes concealed in pre and post mean scores
or group comparison alone.56
Introduction
Pain is defined as “an unpleasant sensory and emotional experience
associated with actual or potential tissue damage or described in terms of such
damage.” (International Association of the Study of Pain, 1986). Many people have
pain that lasts for a long time that is not relieved or cured by physical therapy or
medicines. It is a subjective experience that affects one in five European adults
(Breivik, Collett, Ventafridda, Cohen & Gallacher, 2006) and interferes with emotional,
social, as well as physical functioning. Exploring psychology’s role in managing pain,
Eccleston (2001) observes patients’ search for a diagnosis and for pain relief is often
long, discouraging, and inevitably is damaging psychologically and physically. Ways
of coping that are clinically encouraged and adaptive in acute pain episodes can
become unhelpful and maladaptive in persistent pain (Zarnegar & Daniel, 2005).
The relationship between thoughts, emotions and biological and behavioural
responses are well documented in the Cognitive Behavioural Therapy (CBT) literature
(Beck, Rush, Shaw & Emery, 1979; Clark, 1986) and responses to pain are no
exception. Distorted perceptions of increased pain equating to more damage are
associated with anxiety and unhelpful fears or beliefs that ‘pain means that I am
damaging my body’ or ‘moving will damage my body further’ (Zarnegar & Daniel,
2005). Patients’ then become avoidant of activity which, in turn, contributes
significantly to disability in many pain patients (Vlaeyen and Linton, 2000 & 2012).
Though not always inevitable, these behaviours are thought to be reversible,
at least to some extent, using a rehabilitation or management approach which aims
to reduce disability and distress despite continuing pain (Williams, Eccleston, Morley,
2012). The treatments are based on robust psychological principles and practices and
have been in continuous development for about 40 years. Patients are encouraged to
adopt more helpful beliefs and behaviours that lead to less emotional distress and
disability and therefore less dependence on medical services and better quality of life.57
Current evidence suggests that psychological characteristics are more reliable
determinants of outcome from CBT than demographic data, medical diagnosis or
physical findings (McCracken & Turk, 2002).
A recent systematic review of cognitive behavioural therapy (CBT) for chronic
pain has shown that, compared with waiting list controls, CBT has small effects on
pain and disability respectively but is effective in altering mood and catastrophising
outcomes which are sustained over 6 months (Williams et al., 2012). However, they
conclude that attempting to determine which components of pain management
programmes are factors in better outcomes is not possible given that components
interact in their effects on outcomes. Thorn and Burns (2011) are in agreement when
they observe that we can state that many psychosocial interventions reduce pain and
distress and increase physical function, but we cannot state definitively why this is the
case.
Some of the difficulty lies in the heterogeneity of the population. Even when
pain patients experience similar symptoms, there are differences in underlying
physical and psychological contributions, existing coping mechanisms, general health
and social and cultural background. It may also be that change in some outcomes
may be needed to facilitate change in others. For example, changes in beliefs and
thinking might mediate other changes that outcome studies are not designed to
identify (Laurenceau, Hayes & Feldman, 2007; Thorn & Burns, 2011). Psychological
therapies are one way of helping people with chronic pain reduce negative mood
(depression and anxiety), disability, and in some cases pain, but empirical evidence
is lacking on the best content, duration, intensity, and format of treatment.
Turk (2005) suggests that pain management programmes need to be more
tailored to individual needs and characteristics in order to increase their effectiveness.
The lack of a coherent theory means patients tend to get sub-grouped by non-
psychological means such as diagnosis or from superficial non-functional58
characteristics elicited by questionnaires (Williams et al., 2012). Neither strategy is
likely to be helpful in identifying what works for whom (Vlaeyen and Morley, 2005).
While there is solid evidence that rehabilitative cognitive and behavioural
treatment for persistent pain is effective in improving activity levels, mood, and to a
lesser extent, reducing pain, those results use averages across people. They
therefore cannot tell us about the process of change, which is important to understand
in order to maximise benefits to patients. Single case design is the repeated collection
of quantifiable data on a single case or client. Unlike case studies it adopts a more
idiographic, scientific approach where the level of analysis is primarily the client
(Kazdin, 1982; Morley, 1996), and the focus is on within-subject variability (Barlow,
2008). It can also answer questions around process variables as well as efficacy.
Therefore, by utilising a more individually-focused research method that
follows patient change trajectories over time (such as single case design) clinicians
can contribute significantly to generating hypotheses about how to distinguish these
patients from one another. Previously successful studies by single case researchers
in depression have, for example, identified a pattern of early rapid response where
symptoms significantly decrease by sessionfour and then level off (Ilardi &Craighead,
1999). Another example is the sudden gains theory of Tang and DeRubeis (1999),
who noticed a large improvement in a between- session interval that does not reverse.
Pain management programmes are manualised multidisciplinary CBT
programmes that aim to help patients learn self-management strategies to reduce the
distress and disabilities associated with chronic musculoskeletal, orofacial and
urogenital and pelvic pain, and to improve function and quality of life (Lee, Daniel &
Brook, 2009). The overall aim is not to cure the pain, which has proved resistant to
medical and physical attempts to treat it, but to reduce the distress and disability that
pain causes. It usually employs a multidisciplinary team consisting of clinical
psychologists, physiotherapists, specialist pain doctors and a pain nurse. The team59
help the patient understand and implement a self-management approach to their pain
by first assessing beliefs about cause of their pain, associated thoughts, feelings and
behaviours, coping strategies currently employed and the impact on their life. These
then form the basis of agreed goals for intervention.
The Pain Management Centre of a Central London University College Hospital
runs well established pain management programmes involving an experienced team
of psychologists, physiotherapists, pain specialists and nursing staff. They regularly
show good results in routine evaluation and so provided a useful platform for this
research. Individual pain patients were recruited from the Pain Management Centre
and repeatedly assessed before, during and after treatment, as well as during
intervention to gain insight into the individual process of change for pain patients.
Aims
CBT has been proved as an effective treatment for the management of chronic
pain although it is not yet understood what components of treatment are most
influential for beneficial outcomes. Building on previous findings of multicomponent
multi-outcome Randomised Controlled Trials (RCT), this study uses an idiographic
approach to identify relationships or trajectories which might lead to hypotheses about
participant change in a CBT pain management programme.
Method
Setting
The research took place at the Pain Management Centre of a Central London
University College Hospital. It is well established as a centre of excellence for the
treatment and management of chronic pain as well as the UK’s largest dedicated
Neurological and Neurosurgical hospital.60
Participants
Sampling method. Clinicians screened patients at assessment for their ability
and willingness to cope with the nature and commitment required to participate in this
study. Information sheets and consent forms were utilised as part of the recruitment
following favourable ethics approval detailed below.
Inclusion and Exclusion Criteria. Participants were required to meet the
inclusion and exclusion criteria for the relevant pain management programme.
Inclusion criteria were: 1) 18 years or older and 2) have a diagnosed chronic pain
condition. Exclusion criteria were: 1) actively suicidal 2) actively using illicit drugs or
excessive alcohol; 3) have current cancer pain due to a malignancy and 4) an inability
to understand English in a group. The only additional inclusion criterion for this
research was that in order to complete the required data set they needed to be willing
or able to use the internet, email or post.
Ethical Approval
The research was granted proportionate ethical approval by The National
Research Ethics London Fulham Committee – 13/LO/0940 (see appendix 4)
Procedure
Recruitment. Patients were identified at the formal assessment stage and
approached by the assessing Clinical Psychologist, independently of the research
team. Following their informal consent to be considered they were given an
information sheet (see appendix 5) to read. Their contact information was passed to
the researcher by the clinical lead either directly by telephone or via secure email to61
preserve confidentiality of patient information. A follow-up contact was then made by
phone by the researcher no later than seven days after the assessment. The patients
were asked if they understood the purpose and requirements of the study and were
encouraged to ask questions. Arrangements were then made with the researcher to
complete consent forms (see appendix 6) and instructions were relayed as to how
they would receive the surveys (i.e. by email or post) and a start date was agreed for
their participation.
Data collection. Consenting patients commenced completing standardised
outcome measures on a twice-weekly basis up to four weeks before the start of their
allocated programme, and using the data response mechanism of their choice
(internet, email or post). This was to establish a baseline that enabled the research
team to analyse how stable their current difficulties are before treatment commences.
The patients then started their therapy, and completed twice-weekly assessments up
to, and including, four weeks after their programme finished. The research culminated
with a short telephone interview conducted by the researcher.
The collected data was downloaded and stored securely for future analysis on
University password-protected computers. Patients were offered the opportunity to
ask any questions during the telephone interview and referred back to the information
sheet that contained full contact details. Once the researcher had ascertained that all
the data was present then the patient was thanked for participation, and given the
cash incentive in vouchers via a thank you letter and offered inclusion in the wider
dissemination post write up.
Software. To facilitate secure electronic data collection this study used a
University College London in-house web-based survey tool called Opinio v6.7.2. It
provided a framework for authoring and distributing surveys via the internet and email
as well as multiple reporting formats. Participants who elected to use this method62
would receive bi-weekly email hyperlinks that would prompt and remind them to
complete that day’s survey. The software also allowed the researchers to monitor
incomplete surveys and remind participants to help prevent missing data.
Treatment Intervention
Pain management programme. Patients are commonly referred to pain
management programmes following unsuccessful attempts to resolve their pain by
specialist pain care teams or consultants. The programme first offers patients an initial
information session to orient them to the theory and practice of pain management
where, if they decide to opt into treatment, they are offered a choice of assessment
dates where they are asked to complete some standardised questionnaires and basic
physical ability tests by the team physiotherapist.
Patients are then allocated a pain management programme tailored to their
specific type of, or location of pain i.e. chronic musculoskeletal, orofacial and
urogenital and pelvic pain. There they receive a manualised multidisciplinary CBT
programme of differing durations (COPE for chronic musculoskeletal pain - eight day-
long sessions usually once per week but in some cases twice per week; LINK for
urogenital and pelvic pain - seven day-long sessions over seven weeks; ABOUT
FACE for facial pain - 3 hours once a week for six weeks.
In each of the programmes a multidisciplinary team consisting of clinical
psychologists, physiotherapists, specialist pain doctor and pain nurse help the patient
understand and implement a self-management approach to their pain. They are first
educated about the biological mechanisms of pain. The team will then assist them to
uncover beliefs about causes of their pain, associated thoughts, feelings and
behaviours, coping strategies currently employed and the impact on their life. These
then form the basis of agreed goals for intervention using cognitive/ behavioural and
acceptance and commitment approaches designed to increase psychological63
flexibility. The overall aim is not to cure the pain, which has proved resistant to medical
and physical attempts to treat it, but to reduce the distress and disability that it causes.
Other practical self-management strategies to reduce the distress and disability
associated with their pain are also introduced such as relaxation and mindfulness,
stretching and pacing and advice about sleep.
All programmes come with the addition of a one month, five month and twelve
month follow-up session. The programme is run in a group format, with 8-10
participants all starting at the same time. There are approximately 6-8 weeks between
the assessment and the start of their intervention, during which time the participants
would complete their baseline measures twice weekly. Following the start of
treatment and up to the one month follow-up session patients would also be measured
twice weekly by the researcher.
Design
This study utilises an AB single case design (Barlow, Nock & Herson, 2008).
A and B represent series of repeated observations under two conditions: baseline (A)
and treatment and post treatment (B). By taking repeated measures, issues of
reactivity, regression and maturation can be controlled for as any unusual trends in
these would be expected to show in the baseline data (McMillan & Morley, 2010).
“Hence if the participants’ problems are reasonably stable during baseline and
treatment phases, despite the documented presence of various events, it is not
unreasonable to infer that any major change occurring at the time of introducing
treatment is due to the treatment” (p112).
This study chose a twice weekly frequency of data collection that represented
a two to four day gap between measurements (allowing for weekends). By minimising
the time lag between the experience of an event and the recording of an event it was
hoped that this might lessen any biases due to length of recall (Laurenceau, Hayes &64
Feldman, 2007). This schedule was maintained throughout the baseline, intervention
and follow-up. During intervention it was ensured that measurement was before and
after participants’ pain programme session to allow time for reflection of their learning
and to experiment with new techniques while not inducing fatigue. Using what Bolger,
Davis & Rafaeli (2003) call a signal-contingent design, participants would then receive
email links as prompts to complete assessments at the allocated time points (except
those who that opted for postal assessment where calendar entries were agreed for
all measures and provision for day and date was included in the assessment sheets).
Measures
Outcome measures were selected that had clinical relevance to this study
population and complimented the current assessment battery used by the PMC
(except where some had single items extracted from them). This allowed continuity in
measurement by aligning this study with the aims of the programme. There is also
good evidence of improvement in these domains following PMP interventions and so
it was increasingly likely that we would see change and enable single case methods
to explore why, how and when. In addition, the authors sourced measures that
assessed other facets of the programme, i.e. goal setting, what might be happening
outside of the programme, adherence and process issues and therapeutic alliance. In
addition, a qualitative measure and question about external factors were included to
capture patients own reflections on the process of change and factors outside of
therapy that may have had an influence on them. All measures were completed at
multiple time points before, during and four weeks after treatment (see table 2):
Pain Catastrophizing Scale (PCS; Sullivan & Bishop, 1995). This is a 13- item
self-completion measure of catastrophizing, sampling the tendency to attend to pain,
to overestimate its threat value and to underestimate the ability to handle that threat.65
Each statement is rated for frequency of having these responses when in pain,
ranging from 0 (not at all) to 4 (all the time), so total scores range from 0 to 52. Internal
consistency is high (Cronbach’s α=0.91: Sullivan & Bishop, 1995) and the test–retest 
reliability is satisfactory for the whole scale (ICC = 0.82) (Chatzidimitriou et al. 2006).
Working Alliance Inventory Short Version (WAI-S) (Tracey & Kokotovic, 1989)
is a shortened version of the WAI (Horvath & Greenberg, 1989). The scale is
completed by both client and therapist separately and consists of twelve items; ten
positively worded and two negatively worded. It uses a seven point Likert scale to
measure three factors of the therapeutic alliance based on Borden’s working alliance
theory: agreement of goals for therapy, tasks or agreement on what is important for
the client to work on and bond between the client and therapist. It is a well-triangulated
measure that is widely used and has good validity data (Elvins & Green, 2008). This
measure was administered at the midpoint and towards the end of the programme to
ensure that both parties had sufficient exposure to each other to form an accurate
assessment of their therapeutic relationship.
Single Item Questions. The use of single item questions is preferred to
repeatedly administering whole measures (apart from the PCS which was more
difficult to deconstruct), which could become burdensome for participants when
repeated over numerous time points. Therefore single items from reliable measures
currently in use in the Pain Management Programme assessment at the NHNN or
from other validated measures in this patient group have been extracted. Specifically,
the items for each measure that proved most reliable and sensitive in the original or
subsequent factor analysis of the measure were extracted to offer maximum
sensitivity.
Mood. As a repeated measure of mood this study used an item from the Brief
Pain Inventory (BPI) (Cleeland, 1994). The BPI is a self-report measure designed with
the intention of assessing pain intensity and pain interference. It uses a numeric rating66
scale where 0 represents “does not interfere” and 10 indicates “interferes completely.”
The item asks the participant:
Circle the one number that describes how, during the past 24 hours, pain has
interfered with your mood.
Does Not Interfere Interferes Completely
0 1 2 3 4 5 6 7 8 9 10
Self-efficacy. Taken from the Pain Self-Efficacy Questionnaire (PSEQ;
Nicholas, 2007) a self- report questionnaire used to assess confidence in being active
in ten different areas despite pain. Each statement (e.g. I can enjoy things despite the
pain) is followed by a seven-point scale ranging from 0 (not at all confident) to 6
(completely confident). This measure has been shown to have good test–retest
reliability  and  a  high  internal  consistency  (e.g.,  Cronbach’s  α=  0.92:  Asghari  & 
Nicholas, 2001). Item 1 was used to represent the whole set:
I can still enjoy things despite the pain
0 1 2 3 4 5 6
Not at all Completely
confident confident
Medication. This single item is also from the PSEQ and reflects any changes
in the participant’s reliance on medication during the study that would be an indicator
of improvement in symptoms.
I can cope with my pain without medication
0 1 2 3 4 5 6
Not at all Completely
confident confident67
Adherence to intervention. Taken from previous study by Curran, Williams and
Potts (2009), the measures of adherence are designed to assess how much
participants are adhering to the programme outside of the sessions by using
frequency data.
Exercise frequency. Patients reported the frequency with which they
completed an individualised set of exercises practiced during treatment by endorsing
one of six categories, from 1, stopped completely, to 6, performed daily.
Stretch frequency. Patients reported the frequency with which they practiced
stretching routines learned during treatment. They did this by endorsing one of six
categories, from 1, stopped completely, to 6, performed daily.
Pacing frequency. Patients reported the frequency of using activity pacing
methods (breaking activities down into small manageable steps and building up
gradually; regularly taking breaks or changing position) as developed during
treatment. They did this by endorsing one of six categories, from 1, stopped
completely, to 6, performed at least daily.
Pacing occasion. Using a categorical scale, patients reported how they used
pacing methods by endorsing one or more of six categories, where 1 = not at all, 2 =
when I remember, 3 = when the pain is bad, 4 = for some activities, 5 = indoors only
and 6 = as a daily approach.
Cognitive techniques frequency. Patients reported how often they were using
the methods taught for challenging and changing unhelpful thoughts (e.g. identifying
thought biases and looking for evidence). They did this by ticking one of six
categories, where 1 = stopped completely and 6 = at least once a day.
Cognitive techniques occasion. Using an ordinal scale, patients reported how
they used the cognitive techniques, where 1 = not at all, 2 = when I remember,
3=when the pain is bad, 4=when I am anxious, 5=when I’m depressed, 6 = when
someone upsets me, and 7 = as a daily approach. These were recoded into a68
hierarchy as follows: 1 = not at all, 2 = when the pain is bad or when I remember, 3 =
when I’m depressed, when I’m anxious, or if someone upsets me, and 4 = as a daily
approach. As with occasion of pacing, this reflected the least to most desirable use,
according to treatment recommendations.
External Factors
Cook and Campbell (1979) highlight potential threats to internal validity faced
by single case design and suggest measures are included to validate that any change
is due to the intervention and not other external or social factors. Therefore, a question
to address this has been included:
Have other factors outside of this treatment affected how you are now?
not at all - - - - - - - completely
Please explain further if you wish
....................................................................................................................
Personal goals for therapy. As part of the programme, participants were asked
to formulate some personal goals for treatment and progress towards these were
assessed weekly using goal-based outcomes (GBOs). Designed originally for
activation and engagement with young people in a Child and Adolescent Mental
Health setting, this is a way to evaluate progresstowards a goal. They simply compare
how far a participant feels he/she has moved towards reaching a goal they set at the
beginning of an intervention, compared to where they are at the end of an intervention
(or after some specified period of input). GBOs use a simple scale from 0-10 to
capture the change (0 = not at all met, 5 = half way to reaching this goal, 10 = goal
reached). The outcome was the amount of movement along the scale from the start
to the end of the intervention. (CORC website, www.corc.uk.net)69
Qualitative interviews. Specific questions that were considered useful for this
study were selected by the author from the Change Interview (Elliott et al., 2001). The
rationale being that a qualitative interview may be more sensitive to negative or
unexpected effects McLeod (2001). A short 'debriefing' interview was conducted with
each participant by phone approximately one month after the end of the programme
and once all data was complete. The interview was audio recorded with the
participant’s consent. Interviews lasted approximately 20-30 minutes and participants
were informed that the researcher was independent of the service and encouraged to
be open and honest:
1. What changes, if any, have you noticed in yourself since therapy started? (For
example, are you doing, feeling, or thinking differently from the way you did before?
What specific ideas, if any, have you gotten from therapy so far, including ideas about
yourself or other people?)
2. What areas, if any, do you feel you made the most change and why?
3. Has anything changed for the worse for you since therapy started?
4. Is there anything that you wanted to change that hasn’t since therapy started?
(Goals)
5. What were the most useful aspects of therapy?
6. In general, what do you think has caused these various changes? In other words,
what do you think might have brought them about?
Analysis
Recent developments in quantitative statistical analysis of single case data
either require randomised, alternating or reversal treatment study design of more than
30 – 40 time point measurements to be reliable. This would require more than bi-
weekly sampling in this case and so was deemed unsuitable for this population.70
Outcome data of single case studies can instead, or also, be analysed
graphically following guidance by Morley & Adams (1991). They offer methods of
systematically exploring data using measures of central tendency, linear and non-
linear trend, and displaying variability and non-variability over time. Hayes,
Laurenceau, Feldman, Strauss, Cardaciotto (2007) suggest that plotting these
measures on a chart can also demonstrate the trajectory of change.
Table 1. 9
Time points of measurement of outcome measures
Time Points Measures administered
Baseline (0-4 wks) PCS, BPI SIQ, PSEQ SIQ x2,
Programme (5–14 wks) PCS, BPI SI, PSEQ SI x2, FOT, GBO, ADR
Mid & End Point WAI Therapist and Participant
Follow-up (14-18 wks) PCS, BPI SI, PSEQ SI x2, FOT, GBO, ADR
Follow-up Interview ECI
Note: PCS = Pain Catastrophising Questionnaire; BPI SIQ = Brief Pain Inventory;
Single Item Question (Mood); PSEQ SIQ = Pain Self Efficacy Questionnaire Single
Item Question; WAI = Working Alliance Inventory; FOT = Factors Outside
Treatment; GBO = Goal Based Outcomes; ADR = Adherence to programme; ECI
= Elliot Change Interview.
The reliable change index (RCI) (Jacobson & Truax, 1991) was computed for
each measure that had a reliable reported coefficient (i.e. PCS, BPI Mood, PSEQ).
Where single items had been extracted from standardised measures then the overall
coefficient was adopted. It was considered that RCI methodology has the advantage
of setting criteria for determining whether the magnitude of observed change is or is71
not spurious (attributable to measurement error) (see Morley, Williams & Hussain,
2008).
Qualitative Analysis
Interview data was transcribed verbatim and all personal information was
removed to preserve anonymity. Transcripts were then subjected to thematic analysis
(Braun & Clarke, 2006) involving familiarisation with the data and extraction and
coding of meaningful and interesting features of the dialogue that had a bearing on
the research question. Any commonalities or patterns in codes were organised into
themes. The proposed themes were reviewed in order to maintain an accurate
representation of the data and audited by the research supervisor before adopting
them for reporting.
Results
Due to unforeseen delays in receiving local NHS Trust R&D approval the
August/September 2013 intake assessments were missed which restricted the pool
of potential participants available for selection due to the time restrictions for
completion and submission. Of the fifteen patients that were approached and
informally consented to a follow-up call, eight patients were recruited to the study of
whom seven provided a full set of data. (see Figure 1).72
Figure 1: CONSORT (2010) Participant flow diagram
Five participants were female and two were male. Six participants opted to
complete the surveys via email and one by post. All participants met criteria for chronic
pain (see table 2). One participant dropped out mid-programme for personal reasons
and so did not complete a full data set (P8). The three ABOUT FACE facial pain
patients were the only participants that attended an intervention group together
(including the participant that dropped out of the study). There was no reported non-
attendance by any of the participants, as the programme rules state that they will be
asked to delay their intervention in the case of missing one or two sessions. All73
participants completed a post research change interview by telephone and the
analysed data for each is reported here.
Reliable Change
Table 3 shows participants’ mean scale scores for each measure summarised
at each phase of the intervention (with the exception of the adherence and therapeutic
alliance measures which are summarised separately below). Progress in terms of the
statistical significance of their mean baseline and follow-up scores were calculated
using reliable change based on the co-efficient of each measure cited in the measures
section (see figures in appendices for graphical representation of RCI and all other
measures). The RCI figures in brackets represent where participant scores were
considered below clinical cut off and therefore were unlikely to improve further.
However, these were monitored to check there was no deterioration.
Pain Self-Efficacy Questionnaire item – “I can cope with my pain without
medication”. Additional background to the scores in table 3 and the graphs for this
item, assessment data obtained from the PMC reported that all seven participants
were taking medication for their pain. P2 and P5 both had programme goals to stop
medication and their scores on this item appear to validate their progress. P5 stopped
her medication completely while on the programme. P1 also reported trying to reduce
medication on the programme but was less successful. Both P1 and P7 completed
the intervention and follow-up reporting no confidence at all in coping with their pain
without medication.74
Table 2. 10
Participant demographic data
Participant Prog.
Type
Age Gender Pain
Location
Pain
Duration
(years)
Employment
Status
Referrer
P1 L 56 F Pelvic
Pain
12 Employed GP
P2 C 34 F Back/Hip 18 Unemployed PMC
P3 L 62 M Pelvic
Pain
3 Unemployed PMC
P4 C 25 F Multiple
sites(JHS)
3 Employed Rheumatology
P5 AF 46 F Facial
Pain
14 Employed Dentist
P6 AF 33 M Facial
Pain
12 Employed Dentist
P7 AF 73 F Facial
Pain
11 Retired Neurologist
P8
(discontinued)
AF 48 F Facial
Pain
10 Employed GP
Note: Prog Type: L = LINK; C = COPE; AF = About Face. Pain location: JHC = Joint
Hypermobility Syndrome. Referrer Source: PMC = Pain Management Centre; JHS =
Joint Hypermobility Syndrome.
Goal attainment – goal based outcomes measure. All 7 participants reported
progress on at least one of their goals. P3 and P5 follow-up mean scores indicated
that they had achieved one of the three goals. P6 did not set any goals until post
intervention which is why his start at 0. Also P7 only had one goal set but managed
to show marked improvement on a scale of 1-10. P4 reported little progress towards
achieving goals and showed a reduction in progress between intervention and follow-
up on their primarygoal. However P4 had a high initial rating of attainment, so perhaps
this was showing a more realistic level of current attainment whilst on the programme.
P1 and P2 also reported progress on all three goals.75
Table 3. 11
Summary of mean scale scores per participant across baseline, intervention and
follow-up with RCI interpretation.
Measure P1 P2 P3 P4 P5 P6 P7
PCS:
Baseline 39.1 33.0 12.6 34.5 6.6 18.8 24.4
Intervention 40.9 26.5 7.9 34.3 14.3 18.1 37.5
Follow-up 37.5 20.3 5.9 26.9 7.4 18.3 34.4
RCI NC RC* (NC) NC (NC) NC NC
Single Items:
MOOD:
Baseline 9.9 9.0 3.4 6.5 2.8 4.9 7.3
Intervention 9.8 5.9 2.6 6.7 3.4 4.8 7.0
Follow-up 9.5 4.0 1.3 5.5 1.9 5.8 5.4
RCI NC RC* (NC) NC (NC) NC NC
ENJOY LIFE:
Baseline
0.5 1.5 3.8 2.3 4.5 3.5 2.6
Intervention 1.1 2.3 4.7 2.3 3.7 2.8 3.5
Follow-up 1.3 3.0 5.0 3.0 4.9 2.1 3.4
RCI NC RC* RC* NC NC DET NC
COPE
WITHOUT
MEDS:
Baseline 1.8 1.0 4.8 3.0 0.9 0.9 1.8
Intervention 0.2 2.0 4.9 2.2 1.4 1.0 0.1
Follow-up 0.2 2.6 5.6 2.3 4.6 1.0 0.1
RCI DET RC* (NC) NC RC* NC DET
PROGRESS
TOWARDS
GOALS:
3 of 3 3 of 3 3 of 3 1 of 3 3 of 3 2 of 3 1 of 1
Note: RCI = Reliable Change Index; RC = Reliable Change; NC = No Change; DET = Deterioration:
* denotes reliable change at 95% confidence interval.76
Programme adherence
Exercise and stretching frequency/pacing and cognitive occasion. Similar to
goal attainment, programme adherence could only be measured following attendance
on the programme. Exercise and stretching were frequency data and P2 showed the
most consistent scores reporting adherence to exercise and stretching and utilising
cognitive techniques daily throughout the programme and follow-up. P1 showed
erratic adherence in both, as did P5, with the exception of cognitive techniques which
remained at least once per day until follow-up. P3 and P4 remained relatively stable
on both domains throughout the programme, with P3 showing a slight dip in cognitive
techniques and pacing adherence into the follow-up period. P6 had a lot of data
missing so it was hard to reliably assess adherence. From the data provided it was at
a relatively low daily level. P7 maintained a stable pattern of adherence to exercise
and stretching from once or twice per week to three or four times per week. Their
cognitive techniques and pacing also increased to five to six times per week at the
end of the follow-up measures.
Therapeutic alliance
The Working Alliance Inventory. Table 4 details mean scores and ranges to
assess agreement across four participants and therapists as to their working alliance.
There was some missing or incomplete data for the three remaining participants.
Generally there was consensus for working alliance and no stand out differences at
mid or post intervention. The range of scores tended to be within one or two points for
both participants and therapists with the exception of the participant mid-point score
for item Q7 regarding appreciation of each which showed a range of scores between
1-4.77
Figure 2:4Mean programme and follow-up scores towards individual goals set in the
programme where 0 = no progress and 10 = goal attained.78
Figure 2:5Mean programme and follow-up scores towards individual goals set in the
programme where 0 = no progress and 10 = goal attained.79
Figure 2:6Mean programme and follow-up scores towards individual goals set in the
programme where 0 = no progress and 10 = goal attained.
External events.
Participants utilised the external events questions to varying degrees which
did provide indicators of personal issues that might help to interpret some of the
participants reported scores on assessments. P1 and P5 accounted for the majority
of input (see appendix 13 for table of participant data).
Qualitative Data
The change interview. All seven participants were interviewed using the
revised version of the change interview (Elliot et al., 2001). The resulting thematic
analysis produced four themes and associated sub themes relating to the process of
change. The four themes were (1) components of the programme that had helped;
(2) the process elements of the group e.g. therapeutic alliance, venue issues; (3)
differing modes of support outside the programme; (4) conditions that participants
reported had either hindered or helped them. Each theme is discussed here using
extracts from participants’ transcribed interviews (see table 5).80
Table 4. 12
Mean and range scores for aggregated participant Working Alliance Inventory per
question
Mid Intervention Post Intervention
Question
(mean scale scores where
1=never, 7=always
Participant
mean score
(Range)
Therapist mean
score
(Range)
Participant
mean score
(Range)
Therapist mean
score
(Range)
Q1. Usefulness/Confidence 5.75 (5-6) 5.75 (5-6) 6.25 (5-7) 5 (4-6)
Q2. Likes me 6 (5-7) 5.5 (5-6) 6.5 (6-7) 4.75 (4-6)
Q3. Don't agree 4.25 (3-6) 5.25 (5-6) 4.75 (4-5) 4.75 (4-5)
Q4. Confident in ability to help 2.25 (1-4) 2.25 (2-3) 1.75 (1-2) 2 (2)
Q5. Mutually agreed goals 5.75 (4-7) 5.5 (5-6) 6.5 (6-7) 5.5 (5-6)
Q6. Appreciates me/them 6.25 (5-7) 5.5 (5-6) 6 (5-7) 5 (4-6)
Q7. Agree on what is important 3.75 (3-5) 6.75 (6-7) 4.5 (4-5) 5.75 (5-7)
Q8. Mutual trust 5.75 (5-6) 5.5 (4-6) 6 (5-7) 5.5 (4-7)
Q9. Different ideas of problem 5.25 (4-6) 5.25 (5-6) 5.5 (5-7) 5.25 (4-6)
Q10. Good understanding problems 2.5 (1-4) 2.75 (2-3) 2 (1-3) 2.75 (2-4)
Q11. Working with problem correct 5.25 (4-6) 5.5 (5-6) 6.25 (5-7) 4.75 (4-6)
Q12. Agree improvement 6 (5-7) 5.25 (5-6) 6 (5-7) 5 (4-6)
Programme Components
a) Challenging negative thoughts and feelings. Without exception, participants
felt that there had been a shift in their thinking or in their reactions to their thoughts,
to varying degrees following the programme. They talked about it helping them to
think differently about their pain and recognise potential thinking traps. This maps on
to the specific sessions covered in the programme using examples of common
thinking errors or common traps that patients with chronic pain can fall into:81
P2: well not beating yourself up so much, trying to change your thought patterns so
that you don’t get into the traps of feeling so bad about yourself that it just makes you
feel really low
P5: I think the CBT stuff was most useful for me…. you’re having a thought or you’re
feeling grumpy because, you know, all this kind of stuff - I just think oh yeh I’m having
that thought – well, forget about that, I’ll do something else instead - dealing with it
logically I suppose.
b) Biology of pain/pain mechanisms. More than half of the participants
reported feeling that they understood the physiology of their pain, helping them to
better come to terms with its onset and subsequent trajectory. Participants talked
about never having been given a proper explanation by their consultants or GPs.
There were also some motivators for increasing activity gained from understanding
why hurt does not always equal harm. Participants also felt better able to more
effectively explain their pain to others, and in a way that helped others know how they
could help them. Two sessions in the programmes taught the biology of pain and pain
mechanisms:
P6: It was the physiology stuff you know the explanation of you know the pathways
and you know the mechanisms of pain I found really interesting and really useful.
P2: ..it’s just that the whole experience was enlightening and gave me a new outlook
but also very very importantly it helped me understand what my condition was and
why I was in pain which for 16 years nobody has given me a definite of why even after
my operation you don’t really know what’s happening doctors just talk to you as if
you’re Einstein or something that you understand everything so just understanding82
why I am in pain it was a very very big thing for me to be able to move on to the next
level.
Table 5 13
Thematic analysis
c) Pacing. Pacing is a main component of the programme and something that
was a catalyst for change with over half of the participants. They talked about making
changes in their approach to activity that they would not have considered before the
programme. The consensus was that it helped them to build up their activity and avoid
doing too much or too little especially when in pain or dealing with a flare-up:
Themes and subthemes Number of patients contributing
1. Programme components
a) Challenging thoughts and feelings
b) Biology of pain/Pain mechanisms
c) Pacing
d) Communication with others
2. Process Elements
a) Therapeutic alliance/Respect for professionals
b) Common or shared experiences
c) Communicating changes/Suitability of changes
3. Feeling supported
a) Peer support
b) Support of significant other
c) Family support
4. Indirect moderators of change
a) Therapeutic effect of attendance
7
5
5
4
6
3
2
7
3
3
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P2: Yeh I think the erm it all came from me erm being open and be willing to try out
new things even if they sounded you know completely ridiculous erm you know like
the hoovering just a quarter of the room it you wouldn’t do it it’s not something that
would enter your head oh I’ll just tidy that little bit up and then I’ll go and sit down again
for five minutes it’s not something you trying to do you know you whether do it or you
don’t and I think that just that middle ground finding the middle ground has been very
very helpful.
P3: in doing things but at the same time I’m also aware of the need on some occasions
to sort of restrict what I do so not to sort of go hell for leather all of the time
P4: I don’t feel I have to empty the dishwasher and do the laundry and do the ironing
all in on evening you know it’s okay not to finish a task in a certain amount of time
that’s probably the biggest change to be honest just accepting that and being okay
with it yeh
d) Communication with others. Participants talked about how hard they found
it to talk to others about their pain - a problem that often worsened their pain or mood.
Communication and explaining their pain experience to others was addressed in the
programme. Patients described how a lack of communication can present barriers in
daily life, for example, stopping them from enjoying a holiday or struggling with their
pain rather than asking for assistance:
P3: I think the biggest problem with communications that I had was that I didn’t tell
my wife when things were bad and then she would notice that my mood had changed
and so she would be the one who was asking me how I was rather than me being the
one who told her how I was and I think it is very important to try and take the lead and84
be the one who is not sort of making your partner have to sort of guess how you are
which leads to me being more up front and communicating.
Process Elements
a) Therapeutic alliance. Participants talked about their previous negative
experiences with professionals and how differently the therapists on the programme
treated them. Participants talked about the programme therapists being more
understanding of their pain and less dismissive:
P2: and the way they run the group is absolutely fantastic they speak to you like you
are a human being and they understand you …and that helps a lot to have somebody
- a professional actually -understand and show that they care and that they wanna
help.
b) Common or shared experiences. Some participants reported using the
different pain experiences and motivation of the group to motivate themselves or
challenge their perspectives of their own pain:
P3: But it was also having a course where a lot of people are strongly motivated
makes it good because people sort of want to make it a success and they contribute
more and generally people who’ve done that must have some sort of motivation at
the start otherwise they wouldn’t have done that if you know what I mean?
Others talked about how others experiences had a negative effect on the
group, so that although they cited the same common bond and moving forward
together as being important, they found particular group members presented a barrier
to that.85
P4: they personality wise were quite difficult: each week we’d be talking and trying to
think about how to progress and to work towards our goals, and then they would just
say something along the lines of “well, I’m really glad that I’m going to die soon so I
don’t have to put up with it anymore”.
c) Communicating changes/suitability of changes. Participants commented
about the way logistical issues had been handled and the resulting impact on their
experience, eroding their respect and trust for the clinicians involved and their sense
that staff were working in their best interests. Only two participants commented but
both in strong terms.
P4: think I was frustrated because they had scheduled two ‘family and friends’ days
initially and they sent all the paperwork out to say that they want my family and friends,
and then when we got there they changed the group so it wasn’t - there was only one
family and friends day but they sent my mum away, which was frustrating, and then
all the evaluation forms kept asking “how were the family and friends days”.
Feeling Supported
A common feature of the interviews was how much participants talked about
support from inside and outside the therapeutic frame of the group, and how much of
that was forthcoming as they went through the programme.
a) Peer support. Without exception participants talked about how refreshing it
was to meet other people with the same problems and share experiences. Not only
did they learn from each other but also they reported that they had something to offer
the group in terms of their experience and knowledge from their pain journey, and
offering this was, in itself, therapeutic:86
P3: ..it is a difficult condition and not something you can easily discuss even with
loved ones let alone with other people so it’s been very good from that point of view
in terms of the group being there.
P4: ... that’s been the powerful thing about the group as well just to have a condition
where you’ve never met anybody else with it to be in a room with five other people
who are also upset and who also look absolutely fine you know but don’t yeh but don’t
feel absolutely fine was a really a really powerful thing.
b) Support of significant other. Partners, wives or husbands of participants
were valued where they had also been involved in, or taken on board, the self-
management ethos of the programme. Participants talked about finding partners,
wives or husbands a source of support that had a different approach or meaning than
the therapists or programme members and seemed to help participants’
communication, especially if there were any problems:
P4: …and you know I find that if I’m in a mood or saying certain things he will look at
me and say if you were your patient what would you say you know or what would they
say on the programme.
c) Family support. Reports of family support were mixed in terms of family
members understanding of what participants were trying to achieve on the
programme. Participants talked about how increased understanding or even official
letters from the hospital made a difference to how family supported them. Some also
mentioned existing communication barriers or ways of interacting making support
more difficult:87
P1: I showed the letter to GP to my Mother and daughter and she had not realised
how much pain I was in they both then responded positively and it has changed the
way they are around me.
Indirect Influences on Change
Some participants mentioned effects of the programme contributing to
changes they had made, but indirectly in the sense that they were not intentional on
the part of therapists.
a) Therapeutic effect of attendance. Participants talked about the therapeutic
effect of travelling to the course each week, because it built their confidence to do
more travelling, demonstrated to themselves how much they could do, or provided a
break from a stressful job and time to reflect:
P1: …Encouraged me to get out and given me more confidence to travel on train and
get out and about.
Other items not included in analysis
Two people felt that the programme had imposed particular burdens, one in
travel costs, hotel costs, and guilt over spending money on that (P1), and the other
on completing assessments that s/he found tiring and that tended to lower his/her
mood (P6). One participant reported that s/he had attended a similar course for their
diabetes simultaneously and cited this as perhaps a factor in his/her being able to fully
focus on the programme (P7).88
Discussion
Summary of Results
The effectiveness of a multi-disciplinary pain management programme was
evaluated using single case methods. Clinical outcome measures for catastrophic
thinking, mood, self-efficacy, and goal attainment, and for process measures of
programme adherence and therapeutic alliance, were collected from eight
participants bi-weekly during baseline, intervention and follow-up phases. Seven
participants provided a full set of data. Only one participant showed a reliable change
in all four measures and only two participants showed significant change for self-
efficacy. Three participants deteriorated significantly in self-efficacy single items with
most others showing no change across the board. The overall pattern of results,
therefore, was not indicative of the effectiveness of the intervention.
Other results of note were that all participants made progress on at least one
of their programme goals with one participant able to stop pain medication completely.
There were also high levels of concordance in working alliance between therapists
and participants across all domains. Working alliance was also highly rated in the
interview analysis with six of the seven participants describing ‘feeling understood’ or
‘treated like a human being’. Working alliance is an important measure of process
and, in a meta-analysis of the existing literature, was identified as a moderate
predictor of outcome in psychotherapy (Martin et al., 2000). One could suggest,
therefore, that the reported high rating of concordance in working alliance suggests
‘ideal conditions’ for therapeutic change were present. As mentioned earlier, this is a
strength of single case design in that it can monitor process variables alongside
efficacy.
There were some observed relationships between adherence and participant
change. For example, P2 reported increased mobility and confidence in walking
without a stick whilst adherence to exercise, pacing and stretching were consistently89
high throughout the programme. However, in developing this adherence measure,
Curran et al. (2009) warned about the limitations of self-reported adherence data that
could encounter social desirability and over estimation effects. Indeed, when one
considers the mechanism of reporting how often a cognitive technique is utilised,
retrospectively, it does seem vulnerable to under- or over- reporting. As a result, this
study was careful not to make too many inferences using this data and would suggest
combining alternative measures of adherence, such as pedometers for pacing.
Some of the fundamental elements of the PMP group were rated highly as
factors for change with participants in their interviews, i.e. challenging thoughts,
teaching about the biology/mechanisms of pain, and pacing. Many patients seek to
understand their pain or why it happened, so facilitating a better understanding helped
to change patients’ perspectives on pain and also helped them communicate their
pain experience to others more effectively. Group cohesion and peer support were
also rated as important by participants and have been highlighted as having significant
effects on outcomes in PMP groups (Williams & Potts, 2010). The universality and
shared experiences helped participants feel that they were not alone in their pain and
had something to offer the group. Like working alliance, peer support is a useful
contextual factor for change. Where therapeutic cohesion can influence outcome it
appears that peer support may have the same effects and merits further exploration.
Other sources of support such as significant others or family members where
available were also valued and offered something different to the group or therapist
support. The observable effects of changes in their activity and psychological
approach to their pain motivated the significant others of some participants to change
too.
PMPs have been shown to have positive effects on mood, catastrophising and
self-efficacy and were selected for this reason, so that change could be observed and
explored using single case design. Much of the pain treatment outcome research90
involves analysis of group means or group measurement, which have confirmed
efficacy of CBT in these domains (Williams, Eccleston & Morley, 2012). Hopefully,
this study has shown that these methods can complement larger trials by taking the
investigation a step further to explore why or how it is effective.
This methodology is still novel in terms of its use in this patient group.
However, single case methods have had some success in psychological research in
terms of locating discontinuous and non-linear trends. Examples of this include the
aforementioned patterns of early rapid response in depressed clients, where
symptoms significantly decrease by sessionfour and then level off (Ilardi &Craighead,
1999), and the sudden gains theory of Tang and DeRubeis (1999), who noticed a
large improvement in a between-session interval that does not reverse. Any
similarities to these studies are not immediately obvious in this study data. Perhaps
one might interpret a participant’s comments regarding his or her biggest change as
‘being taken seriously from day one’ as sudden gain, but this was not observed in
his/her scores.
Implications for Practice
If the aim is to move away from sub-grouping patients using non-psychological
properties such as diagnosis clinicians could adopt more tailored outcome measures
based on their assessment findings. Using automated data collection techniques as
shown in this study makes this process more efficient as multiple replications of
specific outcome measures would have minimal impact on cost or effort. Collected
data can be interrogated and analysed session by session and meaningful time spent
with the patient discussing specific areas for improvement or tackling treatment-
resistant problems. The data could also help facilitate clinical strategy in team
meetings or when planning programme sessions by reviewing the real time data in
meetings. Materials can then be adapted for specific patients or targeted for planning91
in vivo behavioural work. In this way, single case design can complement the natural
focus and concern of the clinician (i.e. how can I help this client?) rather than just
making inferences at a group level (Morley, 2007). As a result, it perhaps stands a
better chance than many other designs of being carried out in standard clinical
practice.
Implications for Research
Single case design gives an enriched understanding of fluctuation in scores.
For example, the graphical representation provides a good illustration of how the
trajectory of the mean scores belies the fluctuation between bi-weekly time points.
Use of the mean as the measure of central tendency by its very nature does not
represent the variability in some of the data. It smoothes the line of trajectory and yet
it is this variability that is at the heart of single case design that helps us to understand
what it is like for the patient as they battle with their pain on a daily basis. Therefore
supporting the data with graphical representation seems essential.
Participant retention was a concern in planning this study, yet seven were
retained out of 8 that started and all seven provided a full set of data. Attrition is
something that can have a negative impact on research outcomes. In a study of
attrition, Hellard, Sinclair, Forbes & Fairley (2001) found that retention was increased
where multiple strategies were employed. Two that resonate with this study’s findings
were increased regular contact and ensuring participants were kept well informed and
encouraged. There are, of course, resource costs that can be attached to this, which
perhaps explains why they are not routinely done. However, this is a useful by-product
of the methodology and should be recognised. All participants were sent bi-weekly
emails, informed when the phases were changing or the assessments were changing,
called by phone for their opinions at the end of the study and individually thanked by
letter. They also had access to the researcher should they have any difficulties or92
questions. Most participants cite involvement in research as valued work and not just
personal gain, so being treated well and respected for their time and effort was
important to them.
The data collection software (Opinio) was a useful tool and very reliable.
Those participants who chose email assessment were hardly troubled by format or
technical issues. There were only two examples of emails not being received and
these tended to be at participant or researcher’s interface where they were blocked
by email filters. The captured data was available in many usefulformats e.g., Microsoft
Excel, SPSS, or in a formatted report. However, Opinio is by design a survey tool so
the reporting function would only allow frequency data that, for most of these
measures, were not useful. Templates are available in formats that can enable data
to be copied and pasted from Opinio to give quicker turnaround so would not impact
on efficiency.
In terms of measurement, future studies might want to utilise more non-
standardised measures to avoid the reliability issues of repeating measures that were
designed for pre and post application only. These could be applied as measures of
peer support or group affiliation effects which have been reported here by participants
as important factors in change. Improvement in the quality of adherence might benefit
from more practical measures like pedometers for pacing or diary methods collected
over shorter periods (Curran et al., 2009). Reliable change often sets steep criteria
where standard deviations (variance) are large, and are only applicable if people start
out with scores in the range of clinical concern. As was observed in this study, certain
participants’ scores were very low at baseline and would never show reliable
improvement, but need to be monitored to detect deterioration should it occur.
Increasing the number of data points would allow for the introduction of more
robust statistical measures. However, most of these methods involve withdrawing,
withholding or changing the order of therapy and so would be deemed unethical in93
this patient group. For that reason, AB design was selected as the most suitable but
it is also considered the weakest of the single case designs due to its vulnerability to
threats to internal validity (where change is due to the passing of time, regression to
the mean, or the occurrence of another event). This study has endeavoured to control
for this by conducting the change interview and including a question about external
issues which highlighted other factors outside the participants’ control that were
experienced as barriers to change.
In their study of pain-related fears, Vlaeyen, de Jong, Geilen, Heuts and van
Breukelen (2001) recommend using multiple baseline design to infer effects when
ethically it is impossible to withdraw treatment (albeit that the effects of treatment don’t
automatically reverse when treatment is withdrawn). Similar to AB design it involves
repeated measurement of the same outcomes in different participants over a pre
intervention outline, with the exception that the length of measurement is varied. The
advantage of this design is it demonstrates that change only occurs when the
intervention is directed at the behaviour, setting, or individual in question (Rizvi &
Nock, 2008). It may also extend the number of data points measured.
Limitations
The desired n for this study was 12, but delays in R&D approval caused a set
of assessments to be missed which would have given access to at least 4 other group
assessments so potentially a substantial increase in participants. Without the delays,
better selection at assessment would have been possible and the associated time
pressures of starting late and adhering to study deadlines would have been reduced.
One participant suggested that the bi-weekly assessments were a burden and, as this
did seem to impact his scores, would also need consideration in future research.
As mentioned previously this study used the same measures multiple times
and over a number of weeks, so there were risks of completion fatigue and recency94
effects in completion. This is unavoidable in the methodology so controls were put in
place, such as the change interview and a question about external events to
counteract these effects. Whilst there is evidence that self-report data is reliable the
optimum recall is 2-3 days.
It is also difficult to ascertain the effect on the results of the differing intensity
and duration of each programme as they catered for the individual pain sites or types.
Whilst the content of each programme was the same, just shortened or intensified,
the orofacial patients did perform less well (other than P4 reducing his/her
medication). Whether one could hypothesise causality to the reduced length of the
programme or their specific type of pain would require further investigation. Ideally,
this study would have sampled more participants and recruited equal numbers across
all programmes. The orofacial patients also were the only participants that were
together in their intervention and there were some comments in the qualitative
interviews about others thoughts or discussion about the burden of the study
measures.
Some of the measures (e.g. PCS) were not designed for such frequent use
and it is difficult to assess the impact this may have had on this study. The
development and use of non-standardised methods is recommended (Barlow, Nock
& Herson, 2008), these being more tailored to each client and individualised at
assessment. However, these are unpublished measures with no reliability data, so
resulting data and analysis would need to be treated with caution. This may also
conflict with the research goals of the programme in terms of data from proven
standardised measures allowing generalisability to populations. Also longer term
measurement, perhaps utilising the programme’s 6-12 month follow-up, would have
been desirable but was not possible in the timescales of this study. Observed levels
of change over such a relatively short intervention and follow-up period without more
evidence are difficult to generalise as typical or sustainable over a longer period.95
This study also recognises that further steps could have been taken to guard
against potential researcher bias in the qualitative methodology. Whilst the final
selection of themes and sub-themes were audited by the research supervisor, other
credibility checks could have also been performed to ensure the integrity of the data
such as: ‘consensus checking’ where several people analyse transcripts to establish
inter-rater reliability: or ‘member checks’ where participants themselves are asked to
validate conclusions made (Elliot, Fischer & Rennie, 1999).
Conclusion
This study has demonstrated the potential strengths of single case design in
trying to understand the trajectory of change in a pain management programme. The
use of repeated measurement prior to, and over the course of, the intervention
illustrated the distinct variability of scores on mood, catastrophic thought and self-
efficacy reflecting the participant’s lived weekly experience of their symptoms. The
assessment of the process variables allowed monitoring of contextual factors proven
to play a part in change, although adherence was less clear. By including a change
interview offered a participants’ view of the research experience and contributed some
useful data on specific treatment ingredients, contextual and indirect factors.
Morgan and Morgan (2001) describe single case design as ‘unashamedly
inductive’ (p124), allowing ‘instant exploration of even the most serendipitous of
results’. Exploration of contextual as well as clinical variables can help researchers to
generate hypothesis as to the what, when and how of change whilst complementing
efficacy studies. The effectiveness of CBT with chronic pain is well documented and
if we can then understand why it works then this helps the clinician answer questions
they face every day, such as why is treatment not working for this client (Morley,
2007).96
One participant attempted to explain in the interview what it was that the
programme had imparted that accounted for his/her change. However, as s/he
grappled for the words it was obvious that s/he knew something had changed and
that the programme was the catalyst. S/he attempted to explain it as “the whole being
greater than the sum of its parts” in that it was not just one thing but the interaction of
all of the programme elements. Yet we have seen here that there have been some
moderate gains in some areas for different participants at different points. In order to
further apply empirical methods to these findings perhaps our research question
should be - are the parts greater than the sum of the whole?97
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Part 3: Critical Appraisal104
Introduction
This critical appraisal will reflect on my experiences in conducting two diverse
pieces of work from the context of the types of research assessed i.e. randomised
controlled trials (RCT) for the systematic review, and single case design for the
empirical paper. It will discuss positive and negative experiences of both in
undertaking this research and discuss the wider implications and learning points I can
take with me into clinical practice.
Researcher Background
I was drawn to health psychology, and particularly chronic pain, as a thesis
topic due to the time I spent as an assistant psychologist co-facilitating a pain
management programme. The prospect of working with my current supervisor, a
leader of research in this field, was also a good learning opportunity. I am also
interested in entering health psychology as a service area for future practice. Chronic
and acute illness sometimes belies the fact that people had a life before and so the
challenge is to help them regain some of that “normality”.
Both research tasks were challenging in different ways. For example, I
preferred the more personable approach of the single case design and felt in my
comfort zone. Whereas the meta-analysis was getting to grips with the new, rigorous
and time consuming methodology. I reflect on my experiences here.
Meta-analysis
Pettigrew and Gilbody (2004) recognize the inconsistent nature of research
whereby trials studies can be measuring the same thing yet report different outcomes.
Discerning empirically who is right can seem impossible. Systematic review counters
bias, uncertainty and small effect sizes by synthesizing studies and testing them
scientifically and transparently. Cochrane reviews and health researchers such as105
National Institution of Clinical Excellence (NICE) regularly adopt this as a useful
method to ascertain efficacy and advocate appropriate methods of treatment at a
population level.
However, they are time consuming not just because of the rigor of the
methods, but partly due to the lack of standardized reporting of clinical outcome data
and adherence to methodology. As I started to review 10s of RCTs, I was surprised
at the diversity of quality considering their elevated status as the gold standard in
research efficacy. Despite well documented protocols of reporting i.e. CONSORT
(Consolidated Standards of Reporting Trials), IMPAACT (Initiative on Methods,
Measurement, & Pain Assessment in Clinical Trials) few studies were compliant in
reporting findings. I considered that some of the studies perhaps pre-dated
CONSORT although it was formed in 1996 and so has been in existence for nearly
twenty years.
Initiatives such as CONSORT have sought to unify practice across trial
reporting with checklists and list of approved measures of outcome. This then helps
researchers or health providers compare standardized outcomes within populations
and across trials. Potentially, simply adhering to protocol could reduce a significant
burden of work involved in meta-analysis. The very nature of CONSORT being an
‘initiative’ deems compliance optional it seems, although some journals have made it
a criteria for publication. Only one of 16 trials from my meta-analysis reached all 5
criteria for low risk of bias which are deemed protocol items for running an RCT. I
contacted 13 authors for more data as they had indicated in their methods that they
had captured the required data and seven did not respond (although this mean cited
method of communication had changed). Granted this was not their main outcome of
interest in most of the trials but if it is mentioned in the method then it is surely worth
reporting, even if cited as an observation.106
I realise that caution should be exercised in interpreting quality just from bias
rating alone. Higgins (2011) warns that over-reliance on measures of risk of bias (we
used the Yates Scale, 2005) are subject to the influence of the raters e.g
methodological experience and perhaps skews understanding of quality. This was my
experience as there was an obvious disparity of my knowledge compared to my
supervisor who has been immersed in the pain research for many years. I did observe
most studies adopt the flow of participants and attrition chart. However exclusion of
details of randomization, use of the words RCT in the title, reporting all the results
they measured were regular features of each trial.
There was also an issue with the data that was reported as being in various
formats that made it hard to compare like for like. There was a mixture of continuous
and dichotomous variables and so trials were paired together where possible or
calculations made to calculate a summary statistic for aggregation. I therefore
adopted risk ratio as a way of converting data to comparable formats for analysis.
This did not work in every case but did allow more studies to be included in the
analysis. In health research this is actually a favoured reporting method and they
suggest that even SMD can be converted post analysis to observe effects on patient
risk which is useful for health care providers.
Single Case Design
Undertaking single case design was like operating at the opposite end of the
research spectrum. Having reviewed so many studies of sizeable populations that
had taken many years to plan and complete this felt like a much more personal study.
Participants could almost be described as co-researchers, especially listening to them
formulate their own impressions of what has changed. I feel they responded to this
too. I mention in the empirical paper that invariably people do not volunteer for
research with a view of personal gain but generally feel it will bring value or want to107
give something back for the treatment they are getting. This approach felt like it
respected that decision.
The final data showed a lot variability and my first reaction was to compare
means as there was so much data. Finding a way to attribute meaning to this amount
of data points across the different measures initially felt slightly daunting. The strength
of graphical analysis in single case design is, to use the statistical analysis parlance,
“eyeballing” ones data. This made it immediately obvious what each participants’ level
and trajectory of change was. Mean values helped to plot a line of trajectory to see
trends across the three phases, but also served to illustrate the variability in scores
for some participants over the weeks of measurement. It offered a realistic appraisal
of what it must be like to live with chronic pain every day. Combined with external
factors data it was very enlightening. It was also rewarding to see and hear
participants improve in areas of difficulty.
The post research interview was an opportunity to get to hear their
experiences of the group in a way that might usually be written in a feedback forms
or pre and post mean scores. It helped them also to understand what they had been
through. It felt like they were not just an anonymised number on a data sheet but real
people who had real issues. Morley (2007) suggests one of the strengths of single
case methods is the way it taps into what it is to be a clinician and help people. This
resonates with my experience from that point of view.
The data collection software (Opinio) was very user friendly and, where most
participants’ had opted for email assessment, could be automated in advance. I was
able to agree dates for all participants and warn them in advance. I could also see
whether emails had actually been sent and received as well as check daily if they had
been completed. This would then prompt me to remind them if necessary. This study
relied on repeated measurement and so having a reliable secure system in place that
offers real-time data was essential. As I mentioned in the empirical paper there were108
very few technical issues. Participants who chose email assessment (seven of the
eight recruited) were hardly troubled by format or technical issues. Being able to
download the data into multiple formats was also useful as I could start to format
results as they came in which saved a lot of time at the end of the study. Especially
as there were four different groups starting at different times. The software coped
admirably with the complexity.
The professionalism of the pain management centre as well should be
mentioned. All participants’ commented on their warm, knowledgeable and
professional approach to their pain. Working alliance concordance was high and
never came into question. The interaction between researchers and the team was
also supportive, timely and professional. Especially at the assessment phase where,
at one point, it looked unlikely that we would recruit the required number of
participants. Their outcomes are usually very consistent in terms of improvement and
so along with the selected measures we were confident we would see some change
even if it was mild or moderate.
Conclusion
My purpose here is not to belittle or bemoan RCT’s as they have an important
job to do in addressing population-based questions relating to public safety, health,
education, social policy psychological and other research. Indeed they have provided
reliable data on efficacy as the background to bothstudies. I learnt a lot fromreviewing
so many in a small space of time. Pettigrew and Gilbody (2004) cite approximately
6000 studies a year are added to databases for smoking and so methods of
synthesizing and analyzing such big data sets are essential. Meta-analysis fits this
brief nicely. Closer adherence to the well-established protocols for reporting in RCTs
will hopefully make meta-analysis more accessible. The more time it takes to
undertake the less likely health care professionals are to adopt it in practice.109
Single case design is not designed to replace larger studies and indeed cannot
offer the same results. Its strength is in its ability to look at the underlying clinical,
contextual and external factors that affect change in interventions that already have
proven or observed efficacy. The long term goal being to be able to tailor treatment to
definite patient populations. Single case design is still a very novel methodology in
chronic pain research and so hopefully this study will help inform future research.
As a soon to be newly qualified clinical psychologist, I was surprised to hear
how little research is undertaken post training. Part of this research experience has
been to explore research methodology that I can realistically take with me into
practice. I could adopt successfully and within the time restrictions of practice but still
be meaningful. Both meta-analysis and single case I think fit with practice based
evidence models. Session by session monitoring of clients is already common
practice and going one-step further and developing measures to assess anomalies in
therapy feels very manageable.110
References
Higgins, J.P.T., & Green, S. (2011) (editors). Cochrane Handbook for Systematic
Reviews of Interventions, Version 5.1.0: The Cochrane Collaboration, 2011.
Retrieved from www.cochrane-handbook.org.
Morley, S.J, (2007) Single Case Methodology in Psychological Therapy. In: Lindsay
SJE; Powell GE A Handbook of Clinical Adult Psychology, Hove: Psychology
Press & Brunner-Routledge, pp. 822-844.
Petticrew, M., Gilbody, S. (2004). Planning & conducting systematic reviews. In
Michie, S., & Abraham, C. (2004). Health Psychology in Practice. Oxford:
Blackwell111
Appendix 1: Sample Search Strategy
(PsycINFO)
1. exp pain/
2. (chronic* adj6 pain*).mp.
3. 1 and 2
4. (chronic* adj6 (discomfort or ache*)).mp.
5. (chronic* adj6 (fibromyalgia or neuralgi* or dysmenorrhea or
dysmennorrhoea)).ti,ab.
6. 1 or 2 or 3 or 4 or 5
7. exp Psychotherapy/
8. Cognitive Therapy/
9. exp Behavior Therapy/
10. Biofeedback/
11. ((behaviour* or cognitive) adj (therapy or therapies)).mp.
12. (relax* adj6 (technique* or therapy or therapies)).mp.
13. (meditat* or psychotherap*).mp.
14. ((psychological or group) adj (treatment or therapy or therapies)).mp.
15. (self-regulation adj training).mp.
16. (coping adj skill*).mp.
17. (pain-related adj thought*).mp.
18. (behaviour* adj6 rehabilitat*).mp.
19. ((psychoeducation or psycho-education) adj (group or groups)).mp.
20. (mind and ((body adj relaxation) or (relaxation adj technique))).mp.
21. exp dualism/ or exp relaxation/ or exp relaxation therapy/
22. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21
23. 6 and 22
24. (2007* or 2008* or 2009* or 2010* or 2011* or 2012* or 2013*).up.
25. 23 and 24
26. limit 25 to yr="2011 - 2013"112
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Appendix 5: Patient Information Sheet
Patient Information Sheet
“What changes for whom? Exploring the process of change in a pain management
programme using single case study design”
You are being invited to take part in a research study. Before you decide it is important
for you to understand why the research is being done and what it will involve. Please
take time to read the following information sheet carefully. Ask us if there is anything
that is not clear or if you would like more information. Thank you for taking the time
to read this.
What is the purpose of the research study?
There are many studies showing Cognitive Behavioural Therapy (CBT) for persistent
and chronic pain to be effective in improving activity levels, mood and, to some extent,
reducing pain. The pain management programmes at the Pain Management Centre
of the National Hospital, Queen Square, are well established and run by an
experienced team of psychologists, physiotherapists and nurses. Routine evaluation
shows that overall, patients improve in pain, disability and mood.
We need to understand in more detail the changes made by patients before, during,
and after the programme This may help us to deliver treatment more effectively in
future. .
Why have I been chosen?
We have chosen you because you have chronic pain and are being assessed for a
pain programme. We would like to include you in our research if you decide to do the
programme.
Do I have to take part?
It is up to you to decide whether or not to take part in this research. If you do decide
to take part you will be given this information sheet to keep and be asked to sign a
consent form. This does not affect your right in the future to withdraw at any time and
without giving a reason. A decision to withdraw at any time, or a decision not to take
part, will not affect the standard of care you receive.129
What will happen to me if I take part?
In order to monitor in more detail the changes over the course, of treatment, you will
be asked to complete a questionnaire twice each week before, during and after the
programme. The questionnaire should take no more than 20 minutes. It asks about
problems associated with pain that are targeted by the programme.
We realise that it is quite a lot of effort to complete these questionnaires so often. So
other than the times when you attend the programme, we suggest that you might
prefer to use e-mail, telephone, or SMS (mobile phone text) to give us your answers.
Of course, if you prefer to use pen and paper and to post it to us, that is fine. This
would apply on the days you don’t attend during the programme, and in the weeks
before the programme starts, and the month up to follow-up. We hope that this
minimises the demands and gives some flexibility around your lifestyle. There is also
an interview of up to half an hour, by phone, at a time that suits you, at the end of the
research.
What are the possible benefits of taking part?
At this stage of the research there are no additional or intended clinical benefits to
you from taking part in this study. However, the information you give us during this
research can be supplied to you as graphs or tables at the end of the study if you
wish. By way of recognition of the demands of completing the brief questionnaire
multiple times and as an incentive to take part, we offer £15 to each participant who
completes the monitoring and submits a full set of answers.
Will my taking part in this study be kept confidential?
All information that is collected or recorded will be kept strictly confidential and be
accessed and stored for up to 12 months after the study has ended. All participants
will be identified by a code and not include any personally identifiable information
(such as name or address). Your personal information will not be used in any reports
as a result of your participation. We will not access your medical records. Any
participant data not identifiable to the research team may be retained for future use.
What will happen to the results of the research study?
The results of this study will form part of a doctoral thesis. We also intend to publish
the study in peer-reviewed journals and/or report it at conferences, but all data will be
anonymised and no participant will be identifiable.
Who is organising and funding the research?
The study is being organised and funded by University College London as part of a
Doctoral thesis project in Clinical Psychology.
Who has reviewed the study?
This study has been reviewed by the London Fulham NHS Research Ethics
Committee.130
What if there is a problem?
If you wish to complain, or have any concerns about any aspect of the way you have
been approached or treated by members of staff you may have experienced due to
your participation in the research, National Health Service or UCL complaints
mechanisms are available to you. Please ask programme staff if you would like more
information on this.
What happens if something goes wrong?
In the unlikely event that you are harmed by taking part in this study, compensation
may be available. If you suspect that the harm is the result of the Sponsor’s (University
College London) or the Hospital's negligence then you may be able to claim
compensation. After discussing with your research doctor, please make the claim in
writing to Dr Amanda C de C Williams who is the Chief Investigator for the research
and is based at University College London. The Chief Investigator will then pass the
claim to the Sponsor’s Insurers, via the Sponsor’s office. You may have to bear the
costs of the legal action initially, and you should consult a lawyer about this.
Complaints Procedure
The normal NHS complaints mechanism is available to you if you wish to complain
about any aspect of the way you are approached or treated during the course of this
study. Independent information and advice is available from the PALS office. Please
contact:
Patient Advice & Liaison Service
University College Hospital
Hospitals NHS Foundation Trust
Ground Floor
University College Hospital
235, Euston Road
London
NW1 2PQ
Tel No: 0207 380 9975
Contacts for Further Information:
Chief Investigator & Academic Supervisor:
Dr Amanda C de C Williams
Reader
Research Department of Clinical, Educational and Health Psychology
University College London
Gower Street
London131
WC1E 6BT
Email: Amanda.williams@ucl.ac.uk
Telephone: 020 7679 1608
Fax: 020 7916 1989
Andy Pike
Trainee Clinical Psychologist
Research Department of Clinical, Educational and Health Psychology
University College London
Gower St
London
WC1E 6BT
Email:
Telephone:
Thank you for your time and consideration of participation in this study132
Appendix 6: Patient Consent Form
Centre Number:
Study Number:
Patient Identification Number for this trial:
CONSENT FORM
Title of Project: What changes for whom? Exploring the process of change
in a pain management programme using single case study
design.
Name of Researcher: Dr Amanda C de C Williams
Please initial
all boxes
1. I confirm that I have read and understand the information sheet dated
30/07/13 (version 4) for the above study. I have had the opportunity to
consider the information, ask questions and have had these answered
satisfactorily.
2. I understand that my participation is voluntary and that I am free to
withdraw at any time without giving any reason, without my medical care
or legal rights being affected.
3. I understand that the personal information I provide will only be used for
the purposes of this project and not transferred to an organisation outside
of UCL. The information will be treated as strictly confidential and
handled in accordance with the provisions of the Data Protection Act
1998.133
4. I understand that relevant data collected during the study may be looked
at by individuals from UCL, from regulatory authorities or from the NHS
Trust, where it is relevant to my taking part in this research. I give
permission for these individuals to have access to this data.
5. I agree to take part in the above study.
Name of Participant Date Signature
Name of Person Date Signature
taking consent.134
Appendix 7: Graphical representation of reliable change for each measure135
Appendix 8: Graphical representation of pain catastrophising scale
Figure 3 - PCS raw scores and associated mean value for baseline, intervention and
follow-up136
Appendix 9: Graphical representation of mood raw scores per participant
Figure 4 – Single item question raw data for mood and associated mean values for
baseline, intervention and follow-up137
Appendix 10: Graphical representation of PSEQ raw scores for being able to
enjoy life despite the pain per participant
Figure 5 – Plotted PSEQ single item raw scores per participant for “enjoying things
despite the pain” and associated mean value for baseline, intervention and follow-up138
Appendix 11: Graphical representation of PSEQ raw scores for being able to
cope with pain without medication per participant
Figure 6 – Plotted PSEQ single item raw scores per participant for “coping with my
pain without medication” and associated mean value for baseline, intervention and
follow-up139
Appendix 12: Graphical representation of adherence frequency and occasion
scores per participant140
Figure 6 - Exercise Frequency/Stretching Frequency – 1=stopped completely, 2= less
than once per week, 3=once or twice/week, 4=three to four times/week, 5=five to six
times/week, 6=at least once per day, 7=n/a
Pacing Frequency/Cog.Techniques Frequency - 1=not at all, 2=once or twice/week,
3=three to four times/week, 4=five to six times/week, 5=at least once per day, 6=n/a141
Appendix 13: Table of data of external factors
Have any other factors outside treatment affectedhow you are today?
ParticipantID Response Rating (1=notat
all, 5=completely)
P1 I havea Mum,86who willnot answerthephonewhen I ring. Wetakeherfood every other day butsheis leaving itand putting a lot of pressureon us both physically and mentally. Very self centered. 5
I getstressed very easily and haveashort fuse. Used to beina high pressurejobandcould copewith whateverwas thrown atme. Find ithard to copewith how I am now. 5
In a lotof pain yesterday, courseday and theseats really uncomfortableandI cannotsiton thefloor. Thelongdriveto and from London is nothelping 5
Motherinhospitalsohaveto visithereveryday. Carin garagesohaveto usewheelchair- good exercise!! 5
Travelling toandfrom thecourse. Willtry coming by train nextweek butI do usea mobility scooterorwheelchair, so lots of arrangements havehadto bemade.
Thecoursemakes you think aboutpain which is something I try to putbehind me. Thetravelling makes mevery tired. My Mum is in hospital 5
Train journey back.Great'tillMAN.ramps up and outof virgintrains.ramp putup atMAN -'nocard foryourscooter''in thepost- onmorphine&need ramp already there'ramp pulled away & had to struggleup hugestep etc.lotof pain. 5
Been so tired dueto thetrips to London and back.Somethingalways seems to happen tomakemy pain worseand I losesleep overthis. 5
TheLink courseinvolves a lotof traveland theseats atthevenuearenotgood when in pain. Pain really bad Mon/Tue/Wed 5
Thelongjourney to and from theLinkprogrammeis hard work and thechairs arevery hard. 5
Am doubly incontinent&had an accidenton thetrain on theway to London - twice- so very nervous abouttrip back. Christmas coming too soon. 5
Travelto and from London is very exhausting and painful. 5
Travelling tooand from London forthecoursehas been very tiringand painful. Would havebeen betterif been fortnightly foranyonetravelling 4
Mumnowback athomeand even though EVERYONEis telling her/methatshehas to rely onCarers foranything physicaland I mustnotgo to seehereveryday, itis hard formeto letgo and hernotto 'wind meup'. 3
Having to doublecheck EVERYTHING. Thenextmeeting is being held ata differentlocation.I rang venueand I cannotaccess themeeting room on my scooter... 3
I awokeat 4.00am inchronic pain, could notmove. This is thefirsttimeI havebeen in chronic pain when I havebeen resting and I am very frightened. Beenin bed allday. 5
Very disappointed inresponsefrom Linkwhen I found outthatvenuewas notappropriateformeand to behonestfeltI gotmoreoutof meeting otherLadies with pelvic pain. 5
Relief thatthetrips to Link areoverforthetimebeing. Thelastonewas extremely stressful. Wearepencilingin smallgoals everyday to improvequality of life. Only managed oneday as spentmostof thelastfew inbed in pain. 5
Had a lotof pain theselastfew days whichmeantIhavenotbeen outof thehouse. Find this depressing. 5
Pain has been bad and beenin bed a lot. Cannotdo things I wantto and havebeen bad tempered. Closerelationships havesuffered. 4
My therapistfrom Link rightly suggested that Ireducetheamountof morphine. Starteda reduced doseon Monday. Pain worseand feelpoorly butdetermined to persevere. 5
Reducingthemorphineatthebeginningof theweek has increased thepain. A Family mealhad to becancelled and going outwith friends ditto. Getting betterslowly so feelmorepositivetoday. 5
P2 I feelslightly moreconfidentthatI can do things on my own becauseof travelingto and from COPE. 3
I haveused publictransporta lotthis weekandamdrained 3
P3 I havedonemorethan usualand this has madethepain somewhatworse 2
P4 I moved houseattheweekend andhavebeen unwellwith suspectedglandular feverforthelastfourweeks 4
Moved a week ago so stillunpacking 2
On annualleavefrom work 3
Been on annualleavefrom work 2
P5 Difficulty with grumpy work colleagues 4
period pain 2
having hassleatwork 3
hassleatwork, feeling tired 4
A very busy weekatwork. Today I fellasleep at3pm! 3
Had an evening outin London followed by 6hrs nonstop teaching and now I feelknackered! 3
Bitof stress from an exploding fishtank! Otherwisequitea good few days. 2
Manic atwork. Feeltired a lot. 3
Anothermanicday atworkand 2children bickering when I collected themfrom school. 2
Feeling cheerful. Paid off themortgagethis week! 4
menstruation; feeling very irate! 4
Been crying a lot. Justcan'tseem to help it. Haveto hidein theloo when it happens atwork.
Squabbling children sentmeintoa rageyesterday. 3
I keep spending hours crying. Having to hidein theloo to avoid beingseen. Maybemissing themeds. Butteeth arefine! 4
Can'tgetoff thetreadmill. Justfeelconstantly tired 3
Havehad a fun weekend paving thedriveway andfeeltotally tired butproud of it! 5
Easterhols imminent. Looking forward to a break from teaching. 4
P6 Notreally surewhatthis question means. Thepain is very dependenton my generalstress and fatiguelevels, which vary day to day. 1
P7 No reason given 2
No reason given 2
No reason given 2
No reason given 2
No reason given 2
No reason given 2
No reason given 2
No reason given 2
No reason given 3
No reason given 2
No reason given 2
No reason given 2